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Malaria has had a major effect on the human genome, many protective polymorphisms 
such as sickle cell trait having been selected to high frequencies in malaria endemic 
regions1,2. Recently, it was shown that the blood group variant Dantu provides 74% 
protection against all forms of severe malaria in homozygous individuals3-5. This is a similar 
degree of protection to sickle cell trait and considerably greater than the best malaria 
vaccine, but until now the protective mechanism has been unknown. Here, we demonstrate 
a significant impact of Dantu on Plasmodium falciparum-merozoite RBC invasion. Dantu 
was associated with extensive changes to the RBC surface protein repertoire, but 
unexpectedly, inhibition did not correlate with specific RBC-parasite receptor-ligand 
interactions. By following invasion using video microscopy, we found a strong link between 
RBC tension and merozoite invasion and identified a tension threshold above which 
invasion rarely occurred, even in non-Dantu RBCs. Dantu RBCs had higher average tension, 
meaning that a greater proportion resisted invasion. These findings provide both an 
explanation for the malaria-protective effect of Dantu, and fresh insights into why the 
efficiency of P. falciparum invasion might vary across the heterogenous populations of RBCs 
both within and between individuals.  
 
The Dantu polymorphism has been fine-mapped to a structural rearrangement in the 
glycophorin (GYP) gene cluster. This rearrangement of the GYPA and GYPB genes creates two 
copies of a hybrid gene that encodes the Dantu blood group antigen, a novel sialoglycoprotein 
composed of a glycophorin B (GYPB) extracellular domain fused with a glycophorin A (GYPA) 
intracellular domain5. Both GYPA and GYPB play important functional roles in the invasion of 
P. falciparum merozoites into RBCs, being receptors for the P. falciparum erythrocyte-binding 
ligand PfEBA-1756 and the P. falciparum erythrocyte binding ligand 1 (PfEBL-1)7 respectively.  
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Dantu limits red blood cell invasion 
To investigate the impact of Dantu on P. falciparum invasion, we collected RBC samples from 
42 healthy children from Kilifi in Kenya.  Whilst the prevalence of Dantu is limited 
geographically, being found at much lower frequencies across Africa than the sickle mutation 
in HBB (bs), it is found at a minor allele frequency (MAF) of approximately 10% in this region, 
the highest yet described1,3 and higher than that of bs in this same area (MAF ~8%4). To 
eliminate any possible confounding from other large-effect malaria-protective 
polymorphisms, we excluded samples from subjects with either bs or homozygous α-
thalassaemia (Supplementary Table 1). We quantified invasion over one life cycle (Extended 
Data Fig. 1a) using a flow-cytometry-based preference assay8. Parasites were co-cultured 
with differentially labelled Dantu-heterozygous, homozygous, and non-Dantu RBCs, and we 
measured invasion events into each using a fluorescent DNA dye (Supplementary Figure). 
Significantly lower invasion of Dantu RBCs was seen for 3 parasite strains (3D7, Dd2 and 
SAO75), while a similar but non-significant trend was observed for GB4 and 7G8, potentially 
because of technical variation in their growth rates and starting parasitaemias. We chose 
these five strains for their use of varying invasion pathways and their differing reliance on 
GYPA in particular; Dantu limited invasion in all cases. We also observed a trend towards 
greater invasion-resistance by Dantu homozygous than heterozygous RBCs, suggesting a 
dose-dependent effect (Fig. 1a, Supplementary Table 2).  
 
To investigate the specific step at which invasion was impaired, we used time-lapse video 
microscopy to study the invasion process by 3D7 strain parasites. Invasion into Dantu RBCs 
was also significantly decreased in this real-time assay, independently validating the results 
of our FACS-based assays (Fig. 1b and Supplementary Videos 1 and 2). Invasion can be broken 
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down into three phases: pre-invasion, invasion and echinocytosis (Extended Data Fig. 1b). 
Even when successful, the early pre-invasion and subsequent entry steps took significantly 
longer in Dantu homozygous RBCs, suggesting a mechanical resistance to invasion. By 
contrast, we found no significant difference in the strength of attachment between 
merozoites and Dantu RBCs using optical tweezers9 (Extended Data Fig. 2a, Supplementary 
Table 3, and Supplementary Video 3), nor was there a significant difference in the degree of 
membrane deformation10 or echinocytosis triggered by parasites invading RBCs of differing 
Dantu genotype (Extended Data Fig. 2b and c). Overall, these results indicate that Dantu has 
a pleiotropic effect on invasion across both contact and entry phases. 
 
Surface protein composition also affected 
Comparing RBC indices across the Dantu genotypic groups revealed significantly lower mean 
cell volumes (MCVs) and mean cell haemoglobin concentrations in Dantu homozygotes (Table 
1). This suggests that Dantu directly impacts RBC properties, perhaps by altering the 
composition of the RBC surface. Despite the fact that Dantu leaves an intact copy of GYPA 
within the genome5, the surface expression level of GYPA in Dantu RBCs was significantly 
reduced when measured by flow cytometry (Fig. 2a), confirming observations from previous 
studies11. By contrast, surface expression of GYPB was unchanged, while both GYPC, another 
important invasion receptor12, and Band 3 were significantly increased in Dantu RBCs (Fig. 
2a). CR1 levels were lower in heterozygotes compared to the other two genotypes and, 
importantly, we also observed a significantly higher proportion of Dantu cells expressing 
CD71, a marker of younger RBCs that is lost with maturation (Fig. 2a). The conclusion that 
Dantu RBCs might be younger is supported by the higher reticulocyte counts (Table 1), and a 
higher reticulocyte RNA content (Extended Data Fig. 3) in Dantu homozygotes. We saw no 
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differences in the surface expression of other essential RBC membrane proteins including 
Basigin, CD55, CD44, Integrin and Duffy (Fig. 2a).  
 
To quantify these changes more accurately, we employed plasma membrane profiling13 and 
tandem mass tag mass spectrometry to accurately quantify surface proteins. Analyzing RBCs 
from three donors of each type revealed widespread cell surface changes, with 40 proteins 
up- and 34 down-regulated by >50% in Dantu heterozygotes, and 66 proteins up- and 34 
down-regulated by >50% in Dantu homozygotes (Figures 2b, Extended Data Fig. 4, 
Supplementary Table 4). The significant decrease in GYPA expression identified by flow 
cytometry was confirmed by mass spectrometry (Extended Data Fig. 4b), which also 
identified a significant increase in CD71 expression in Dantu homozygotes (Fig. 2b), 
supporting the conclusion that on average, Dantu RBCs are younger than normal RBCs. By 
contrast, the significant increase in GYPC and Band 3 expression in Dantu RBCs observed by 
flow cytometry were not confirmed by mass spectrometry. Given the more quantitative 
nature of mass spectrometry, these are likely the more definitive findings. Mass spectrometry 
also distinguished peptides unique to GYPA (which were all in the extracellular region of the 
protein) from those shared with Dantu (which were all intracellular), confirming the presence 
of Dantu antigen on the RBC surface (Figure 2c, Extended Data Fig. 4). 
 
Two independent methods therefore confirm major changes in Dantu RBC membranes, 
including a significant reduction in the P. falciparum invasion receptor, GYPA. To test whether 
these changes might explain reduced RBC invasion, we investigated invasion by a genetically 
modified P. falciparum strain in which PfEBA175, the ligand for GYPA, had been disrupted14. 
The PfEBA175-GYPA interaction is not essential for invasion, and when PfEBA175 is deleted, 
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other invasion ligands can be transcriptionally up-regulated to compensate for the deletion 
phenotypically14. Invasion of Dantu RBCs by ΔPfEBA175 parasites was also significantly 
reduced (Fig. 2d, Supplementary Table 2). Given that by definition, this parasite cannot use 
GYPA for invasion, the inhibitory impact of Dantu cannot entirely be explained by an altered 
PfEBA175-GYPA interaction. Along with our earlier observations that Dantu decreases 
invasion both by strains known to rely heavily on PfEBA175 (Dd2) and others that are less 
dependent on this pathway (3D7), this observation is further evidence that the impact of 
Dantu is not linked to specific receptor-ligand interactions. 
 
Membrane tension is linked to invasion efficiency 
To explore the broader RBC biomechanical effects of Dantu, we measured membrane contour 
fluctuations16 by combining live imaging with flickering spectrometry17 (Extended Data Fig. 
5), enabling us to generate direct measurements of RBC membrane mechanics such as 
tension, radius, viscosity, and bending modulus. Tension and bending modulus represent the 
resistance of membranes to stretch and bend, respectively. Bending modulus is affected by 
lipid composition, membrane thickness, and membrane asymmetry while tension is set by 
osmotic pressure; the RBC cytoskeleton can affect both. These phenotypes vary naturally 
between RBCs, which can circulate for more than three months after they are produced from 
stem cells. As expected due to their lower MCV, Dantu RBCs had a significantly higher tension 
and smaller radius than non-Dantu RBCs, whereas no significant differences were seen in 
bending modulus and viscosity (Fig. 3a). The equatorial radius difference of 0.3 µm between 
non-Dantu and Dantu is minor, and likely explained by a shape change caused by the 
increased tension. Tension and radius are linked properties, higher tension leading directly to 




To test for a link between tension and invasion, we measured both parameters 
simultaneously using video microscopy. Tension was measured for all RBCs adjacent to a 
rupturing schizont using high frame-rate capture (Supplementary Video 4), then the invasion 
fate of all parasite-RBC contact events with these same RBCs was monitored following 
schizont rupture (Fig. 3b, Supplementary Video 5). We observed an intrinsic distribution of 
membrane tensions in RBCs from each donor and discovered a clear association between 
tension and invasion: merozoites preferentially invaded neighbouring RBCs with low tension 
(Fig. 3c, Supplementary Tables 5 and 6). Comparing the distribution of tension values with 
invasion efficiency suggested a tension threshold for successful invasion that was consistent 
across all three genotype groups. The average of these tension thresholds across the 
genotype groups was 3.8 (±2.0) *10-7 N/m, successful invasion being very rare above this 
threshold both in Dantu and non-Dantu RBCs (Fig. 3c). Critically, the median tension was 
8.2*10-7 N/m in Dantu RBCs, meaning that the majority were above the tension threshold of 
3.8 (±2.0) *10-7 N/m (Fig. 3a). The impact of Dantu on the biomechanical properties of the 
RBC is therefore sufficient to explain its impact on invasion, consistent with the invasion-
inhibitory effect of Dantu being independent of a reliance on GYPs or other invasion 
receptors. 
 
To probe the mechanism by which higher RBC membrane tension results in invasion 
resistance, we examined whether it impedes the merozoite’s ability to wrap the RBC 
membrane around itself during invasion. Imaging at fine resolution established that parasites 
were considerably more wrapped by RBCs with lower membrane tensions (Fig. 3d). 
Consistent with this, there was also an association between tension and RBC deformation 
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during the invasion process, merozoite contacts with higher tension RBCs resulting in less RBC 
membrane deformation (Extended Data Fig. 6b, Supplementary Table 6). 
 
We hypothesized that the molecular mechanism by which membrane tension is increased in 
Dantu RBCs might relate to changes in expression of membrane ion channels and in particular 
SLC9B2, a sodium-hydrogen exchanger that is upregulated in Dantu homozygous RBCs (Fig. 
2b). Increased SLC9B2 expression could lead to increased intracellular sodium levels, 
overhydration and increase membrane tension. To test this hypothesis, we treated Dantu 
RBCs with phloretin, a broad-spectrum inhibitor of ion transporters. Phloretin resulted in 
decreased tension of both Dantu and non-Dantu RBCs (Extended Data Fig. 7), but 
unfortunately, it also inhibited egress of parasites from late-stage infected RBCs, making it 
impossible to test whether phloretin could rescue the invasion inhibitory effect of Dantu. As 
an alternative approach, we perturbed the membrane tension of non-Dantu RBCs by treating 
them with trace concentrations of glutaraldehyde, a compound that has been shown to 
increase RBC membrane tension without affecting bending modulus22, and which therefore 
mimics the biophysical effect of Dantu. Treatment with 0.01% glutaraldehyde increased 
membrane tension in non-Dantu RBCs to levels that were similar to Dantu homozygous RBCs, 
and also caused a 43% reduction in invasion efficiency by 3D7 parasites (Fig. 3e). These data 
confirm the direct impact of RBC membrane tension on parasite invasion efficiency, 
independent of other parameters such as bending modulus. 
 
In summary, we have established a mechanism whereby the complex structural 
polymorphism, Dantu, protects against severe malaria. We demonstrate a marked strain-
transcending inhibition of P. falciparum-invasion into Dantu RBCs, and establish the novel 
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concept that it is the impact of Dantu on RBC membrane tension that mediates this inhibition, 
possibly via changes in the surface expression of membrane transporters that affect RBC 
hydration. By following, for the first time, tension and invasion at single-cell single-event 
resolution, we propose that irrespective of Dantu genotype, there is a tension threshold for 
successful P. falciparum invasion, a novel concept that links our understanding of RBC 
biomechanical properties22,23 to the heterogeneity of parasite invasion. While previous 
studies have broadly linked invasion efficiency to RBC osmotic stress19 and oxidative 
damage20, both manipulations have multiple effects on RBC biomechanical properties, and 
can affect membrane deformability, rigidity, tension and bending modulus20,21 (parameters 
defined in Supplementary Table 7). In this study, we were able to deconstruct these general 
biophysical membrane properties into specific components and demonstrate that it is altered 
tension, but not bending modulus or viscosity, that is associated with impaired invasion into 
Dantu RBCs.  
 
The concept of a tension threshold potentially explains other well-established features of P. 
falciparum invasion, such as their preference for younger RBCs24 which have lower tension 
and higher radii. Several other polymorphisms also affect RBC tension25,26; further studies will 
be required to investigate whether the same mechanism might be generalizable across 
multiple malaria-protective RBC traits. Membrane tension also changes with maturation of 
intracellular parasites27,28, and in other contexts membrane tension has been implicated in 
the regulation of endocytosis29 and the spreading of bacterial pathogens30.  While improving 
our biological understanding of erythrocyte-parasite dynamics, this study also signals the 
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Table and Figure Legends 
 
Table 1 | Clinical and demographic characteristics of study participants.  
Mean values for each clinical and demographic characteristic, with standard deviation (SD) in 
parentheses. n= 17 non-Dantu, 16 Dantu heterozygous and 13 Dantu homozygous individuals. 
Statistical comparison across genotypes was performed using the Kruskal-Wallis test, while 
pairwise comparisons between groups performed using Dunn's test. P adj* - adjusted for age, 
sex and multiple comparisons with Benjamini-Hochberg FDR adjustment. *p < 0.05. 
 
Figure 1. Reduced invasion of Dantu variant RBCs by multiple P. falciparum strains. (a) The 
relative ability of P. falciparum strains from multiple geographic locations (3D7 and GB4 West 
Africa; Dd2 Southeast Asia; SA075 East Africa; 7G8 South America) to invade RBCs was 
measured using a flow cytometry-based preference invasion assay. The percentage of 
parasitised RBCs in each genotype group is indicated on the y-axis. Statistical comparison 
across groups was performed by one-way ANOVA, while pairwise comparisons between 
groups used the Tukey HSD test. Significant differences in invasion were observed between 
non-Dantu and Dantu homozygotes in 3D7 (p=0.001), Dd2 (p=0.015) and SAO75 (p=0.028). 
Statistical data listed in Supplementary Table 2. (b) The invasion process was also followed 
by live video microscopy, where the invasion rate of 3D7 merozoites was measured as the 
proportion of merozoites that contacted and successfully invaded RBCs, relative to all 
merozoites that contacted RBCs. Pre-invasion time - from first merozoite contact through RBC 
membrane deformation and resting; invasion time - from beginning of merozoite 
internalization to beginning of echinocytosis. 6 RBCs per genotype group were tested in both 
flow and video microscopy assays. In the video microscopy assays, the number of contacted 
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and successfully invaded RBCs counted were as follows: non-Dantu: 144/53, Dantu 
heterozygote: 191/43, Dantu homozygote: 233/41. Boxes indicate the median and 
interquartile ranges, while whiskers denote the total data range, with the dots outside the 
whiskers indicating the outliers. Bars show the mean and standard deviation of the video 
microscopy invasion data. Pairwise comparisons between genotypes were performed using 
the two-sided Mann-Whitney U test. **p < 0.01; *p < 0.05. 
 
Figure 2. RBC membrane protein characteristics vary across Dantu genotypes but do not 
directly correlate with invasion efficiency. (a) The relative expression of essential RBC 
membrane proteins was assessed using fluorescent monoclonal antibodies in flow cytometry 
assays. 13 non-Dantu, 12 Dantu heterozygotes and 11 Dantu homozygotes were tested. 
Statistical comparison across groups was performed by one-way ANOVA, while pairwise 
comparisons between groups used the Tukey HSD test. Significant differences were observed 
in GYPA (non-Dantu vs. Dantu homozygote p=6.25x10-11; non-Dantu vs. Dantu heterozygote 
p= 4.62x10-6; Dantu heterozygote vs. Dantu homozygote p= 6.86x10-4), GYPC (non-Dantu vs. 
Dantu homozygote p=0.03), Band3 (non-Dantu vs. Dantu homozygote p=6.25x10-11; non-
Dantu vs. Dantu heterozygote p=0.0136), CD71 (non-Dantu vs. Dantu homozygote p=0.006), 
and CR1 (non-Dantu vs. Dantu heterozygote p=0.003; Dantu heterozygote vs Dantu 
homozygote p=0.045). (b) Scatter plot of all proteins quantified by mass spectrometry (n=3 
RBCs per genotype). Fold change was calculated by average signal:noise (Dantu 
homozygote/non-Dantu). GYPA was split into two parts: identified by peptides unique to 
GYPA (‘GYPA unique’, originating from extracellular region) or shared with the Dantu protein 
(‘GYPA shared’, originating from intracellular region). Mass spectra were processed with the 
quantitative proteomics platform “MassPike” and the method of significance A with 
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Benjamini-Hochberg multiple testing correction was used to estimate the p-value that each 
protein ratio was significantly different to 1. (c) Graph of the relative abundance of ‘unique’ 
and ‘shared’ GYPA peptides across all donors. Signal:noise values were normalised to a 
maximum of 1 for each protein. Statistical data for (b) and (c) listed in Supplementary Table 
4. (d) Comparison of invasion efficiency of a genetically modified parasite strain, ΔPfEBA175, 
across genotypes (n=13 non-Dantu, 12 Dantu heterozygotes and 12 Dantu homozygotes) 
using the flow-cytometry-based preference invasion assay. The percentage of parasitised 
RBCs in each genotype is indicated on the y-axis. Statistical comparison across groups was by 
one-way ANOVA, while pairwise comparisons between groups used the Tukey HSD test (non-
Dantu vs. Dantu homozygote p=0.04). ** p < 0.01; * p < 0.05. 
 
Figure 3. Biomechanical properties of the RBC membrane differ across Dantu genotypes and 
correlate with invasion. (a) Membrane flickering spectrometry enabled measurement and 
comparison of RBC bending modulus, tension, radius, and viscosity across genotypes (n=6 
RBCs per genotype). Mean and standard deviation were obtained from the averages of cell 
tensions for each sample: non-Dantu RBCs - (6.0 ±1.9) *10-7 N/m; Dantu heterozygotes - 
(7.9±2.8) *10-7 N/m; Dantu homozygotes - (8.8 ± 0.7) *10-7 N/m. The impact of tension on 
parasite invasion was evaluated by simultaneously measuring tension from flickering analysis 
and live video imaging of the invasion process from rupturing schizonts (“egress”, 
“deformation”, then either “invasion” and “echinocytosis”, or a failed invasion) (b), in non-
Dantu and Dantu homozygote RBCs (c). The threshold range for tension, marked in (a) and 
(c), was obtained by comparing distributions of tension across Dantu genotypes with their 
invasion efficiency. (d) The contact region between merozoites and RBCs, represented in the 
snapshots, was measured during pre-invasion at the point of RBC maximum deformation for 
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2 sets of very high (n = 15) and low tension (n = 23) cells (p=1.30 x 10-32). Merozoite-RBC 
contact section was significantly smaller in high tension RBCs meaning that parasites were 
much more wrapped around RBCs with a lower membrane tension. (e) Parasite invasion 
efficiency and RBC tension for six increasing concentrations of glutaraldehyde (0.00001 - 
0.01%). Parasite invasion was significantly decreased for RBC tensions around 8.8 x 10-7 N/m 
(22% decrease) and 12.2 x 10-7 N/m (43% decrease). Median values are reported from 2 
technical replicates of 2 biologically independent samples. Pairwise comparisons between 
genotypes used the two-sided Mann-Whitney U test. ** p < 0.01. Number of cells and tension 




Materials and Methods 
Study participants. Samples were obtained from 42 children under the age of 13 years from 
two cohorts from the Kilifi County on the Indian Ocean coast of Kenya, who were involved in 
ongoing studies on malaria: (i) 18 children from a cohort subject to annual cross-sectional 
surveys through which blood samples are collected and frozen, and (ii) 24 children from a 
cohort recruited at 3-12 months of age and followed up for hospital admission since 2007, 
whose blood samples were collected and used in the assays within 24 hours of blood draw. 
Individual written informed consent was provided by the parents of all study participants. 
Ethical approval for the study was granted by the Kenya Medical Research Institute Scientific 
and Ethics Review Unit in Nairobi, Kenya (SERU3420 and SERU3500), the NHS Cambridgeshire 
4 Research Ethics Committee (REC reference 15/EE/0253), and the Wellcome Sanger Institute 
Human Materials and Data Management Committee.  
 
Genotyping Dantu samples. gDNA was extracted from whole blood using a QIAmp 96 DNA 
QIcube HT kit on a QIAcube HT System (QIAGEN) following manufacturer’s instructions. The 
restriction fragment length polymorphism (RFLP) assay to detect genotypes at the Dantu 
marker SNP, rs186873296, has been previously described4,5. Briefly, PCR amplification of the 
region of interest containing rs186873296 was performed using the following primers: 
5’ACGTTGGATGGCAGATTAGCATTCACCCAG3’ and 
5’ACGTTGGATGCTCCAGAGTAAGCATCCTTC3’ generating an amplicon of 124bp. 
Fragmentation of the PCR product was then performed using the CviQI restriction enzyme 
(NEB), which allowed us to differentiate between non-Dantu homozygotes (AA) that would 
remain uncut, Dantu heterozygotes (AG) that would generate two bands of 64 and 56bp, and 




In vitro culture of P. falciparum parasites. All P. falciparum parasite strains used in this study 
(3D7, Dd2, SAO75, GB4, 7G8, ΔPfEBA175) were routinely cultured in human O-erythrocytes 
(NHS Blood and Transplant, Cambridge, UK, and Kenya Medical Research Institute, Nairobi, 
Kenya) at 3% hematocrit in RPMI 1640 medium with 25 mM Hepes, 20 mM glucose, and 25 
μg/mL gentamicin containing 10% Albumax at 37°C (complete medium), under an 
atmosphere of 1% O2, 3% CO2, and 96% N2 (BOC, Guildford, UK). Parasite cultures were 
synchronized on early ring stages with 5% D-sorbitol (Sigma-Aldrich, Dorset, UK). Use of 
erythrocytes from human donors for P. falciparum culture was approved by NHS 
Cambridgeshire 4 Research Ethics Committee and the Kenya Medical Research Institute 
Scientific and Ethics Review Unit.  
 
RBC preference invasion assays. In all cases, blood was collected in EDTA-vacutainers and 
either used within 24h or cryopreserved using standard methods. Both fresh and 
frozen/thawed RBCs from Dantu homozygote, heterozygote and non-Dantu children were 
used in these assays, with no difference in parasite invasion efficiency being observed 
between them (Extended Data Fig. 8). RBCs were stained with three concentrations of 
CellTrace Far Red Cell Proliferation kit (Invitrogen, UK) - 1µM, 4µM and 16µM - corresponding 
to the three genotype groups. After a 2h incubation at 37°C under rotation, the stained RBCs 
were washed and resuspend to 2% Haematocrit (Hct) with complete medium. The cells were 
stored at 4°C until use for up to 24h after staining. To evaluate the preference of the parasites 
to invade RBCs of different Dantu genotype, parasite cultures containing mostly ring forms at 
2-5% parasitaemia were pooled with equal volumes of RBCs from each genotype group (25µl 
pRBCs, 25µl Dantu homozygote RBCs, 25µl Dantu heterozygote RBCs and 25µl non-Dantu 
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RBCs) in the same well in 96-well plates. To evaluate whether the different concentrations of 
the dye could affect parasite growth, parasite cultures were mixed with stained RBCs from 
each genotype group in individual wells in a 1:1 ratio (50µl pRBCs + 50µl stained RBCs), while 
normal parasite growth controls were also evaluated by mixing parasite cultures with 
unstained RBCs from each genotype group in individual wells in a 1:1 ratio (50µl pRBCs + 50µl 
unstained RBCs). The samples were incubated for 48h at 37°C under static conditions as 
described above. After 48h, the cultures were treated with 0.5 mg/mL ribonuclease A (Sigma 
Aldrich, UK) in PBS for 1h at 37°C to remove any trace of RNA. To evaluate all parasitised RBCs, 
the cells were stained with 2x SYBR Green I DNA dye (Invitrogen, Paisley, UK) in PBS for 1 h at 
37°C. Stained samples were examined with a 488nm blue laser, and a 633nm red laser on a 
BD FACS Canto flow cytometer (BD Biosciences, Oxford, UK). SYBR Green I was excited by a 
blue laser and detected by a 530/30 filter. CellTrace Far Red was excited by a red laser and 
detected by a 660/20 filter. BD FACS Diva software (BD Biosciences, Oxford, UK) was used to 
collect 50,000 events for each sample. The data collected were then further analysed with 
FlowJo (Tree Star, Ashland, Oregon) to obtain the percentage of parasitised RBCs within each 
genotype group. Statistical analyses were performed using R statistical software (version 
3.3.3), where differences in invasion across the three Dantu genotype groups were evaluated 
using a one-way ANOVA test, while pairwise comparisons between genotype groups were 
evaluated using the Tukey HSD test. All experiments were carried out in triplicate and the 
data are presented as the median and interquartile ranges of invasion data across samples 
within each genotype group. 
 
Live invasion imaging. All live imaging assays were performed blind to the Dantu genotype 
group. Highly concentrated (97-100%) infected cells (strain 3D7) were isolated by magnetic 
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separation (LD columns, Miltenyi Biotec, UK) directly before the experiments and re-
suspended in complete medium either with Dantu or non-Dantu RBCs at 0.2 % Hct. The Dantu 
and non-Dantu RBCs suspensions were loaded in separate SecureSeal Hybridization 
Chambers (Sigma-Aldrich) and imaging was performed at the same time by employing 3 
microscopes in order to guarantee the same conditions throughout the experiments. Each 
sample was recorded for about 2 hours to enable recording of a sufficient number of events. 
A custom-built temperature control system was used to maintain the optimal culture 
temperature of 37°C while running these experiments. Samples were placed in contact with 
a transparent glass heater driven by a PID temperature controller in a feedback loop with the 
thermocouple attached to the glass slide. A Nikon Eclipse Ti-E inverted microscope (Nikon, 
Japan) was used with a Nikon 60X Plan Apo VC N.A. 1.40 oil immersion objective, kept at 
physiological temperature through a heated collar. Motorised functions of the microscope 
were controlled via custom software written in-house and focus was maintained throughout 
the experiments using the Nikon “Perfect Focus system”. Images were acquired in bright-field 
with red filter using a CMOS camera (model GS3-U3-23S6M-C, Point Grey Research/FLIR 
Integrated Imaging Solutions (Machine Vision), Ri Inc., Canada) at a frame rate of 4 fps, with 
pixel size corresponding to 0.0986 µm. We recorded one video for each egress-invasion event, 
from a few minutes before schizont rupture until the end of echinocytosis, around 20 minutes 
after egress. For each video, the duration of all the phases of an invasion process was assessed 
by two scientists independently, according to the following definitions of intervals: (i) ‘pre-
invasion’ the time from the first evident contact between merozoite and RBC, throughout 
RBC deformation and subsequent resting; (ii) ‘invasion’ from the beginning of merozoite 
penetration of RBC throughout its complete internalisation until the beginning of 
echinocytosis; and finally (iii) ‘echinocytosis’ from the first curling of the RBC edge to the 
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recovery of its normal biconcave shape. Our measurements of invasion time are slightly 
longer than previous studies, which did not include the resting time from the end of parasite 
internalisation to the start of echinocytosis in their assessment of invasion time10,31. The 
parasite invasion efficiency or proportion of invasion has been quantified as the fraction of 
merozoites that contacted and successfully invaded RBCs divided by the number of all 
merozoites that contacted nearby RBCs post-egress, expressed as a percentage. This 
definition took into account the fact that in a chamber, we can have multiple invasions when 
more merozoites invade the same RBC. The degree to which merozoites deformed RBCs 
during invasion was given by a simplified four-point deformation scale (0, 1, 2, and 3), based 
on the most extreme degree of deformation achieved10. The visual assessment was done 
independently by two different experimentalists who were blinded to the genotypes of the 
RBCs in each video. We analysed six different RBC samples per genotype group, with data 
from 3 technical replicates. The total number of RBCs contacted by merozoites were: 155 for 
non-Dantu, 191 for Dantu heterozygotes, and 233 for Dantu homozygotes. The total number 
of successfully invaded cells were: 53 for non-Dantu, 43 for Dantu heterozygotes, and 41 for 
Dantu-homozygotes. The contact region between the merozoite and the RBC surface when 
the parasite deforms the host cell at its maximum was measured for 20 RBCs with both very 
high and very low tension from three different samples. Image thresholding filters (ImageJ) 
were used to distinguish the parasite and RBC contours from videos taken in bright-field at 
100 fps. Only when merozoites were poised laterally to the RBC the thresholding process 
accurately identified them, and therefore only lateral invasions as in Fig. 3d were taken into 
account for this analysis. Both successful and failed invasions were considered, but as already 






Optical tweezers. The optical tweezers are built within the same Nikon inverted microscope 
used for imaging and consist of a solid-state pumped Nd:YAG laser (IRCL-2W-1064; 
CrystaLaser, Reno, NV) having 2W optical output at a wavelength of 1064 nm. The laser beam 
was steered via a pair of acousto-optical deflectors (AA Opto-Electronic, Orsay, France) 
controlled by custom-built electronics that allow multiple trapping with subnanometer 
position resolution. Videos were taken at 60 fps through a 60X Plan Apo VC 1.20 NA water 
objective (Nikon) with pixel size corresponding to 0.0973 µm.  Dantu and non-Dantu RBCs 
were suspended in complete medium at 0.05 % Hct with purified schizonts and loaded in 
separate chambers coated with 10 µl solution of poly(l-lysine)-graft-poly(ethylene glycol) 
(PLL-g-PEG) (SuSoS AG, Dübendorf, Switzerland) at 0.5 mg/mL concentration and incubated 
for 30 minutes to prevent excessive adherence of cell proteins onto the coverslip. Adhesive 
forces at the merozoite-erythrocyte interface were quantified by evaluating the elastic 
morphological response of the erythrocyte as it resisted merozoite detachment9. 
Immediately after schizont egress, merozoites were manipulated by optical trapping and 
delivered to the surface of uninfected erythrocytes until attachment. Trapping durations were 
kept short (< 10 seconds) to minimise any possible detrimental effect of local heating: at full 
laser power, a few degrees Celsius of heating are expected locally around the laser beam 
focus.  Then a second red blood cell was delivered close to the merozoite to form an 
erythrocyte-merozoite-erythrocyte system9. Erythrocyte maximal elongation before 
detachment was measured by pulling away the erythrocyte that adheres to the merozoite 
from their point of attachment, while the opposing force, on a second erythrocyte of our 
system, is given by either a second optical trap or by adhesion to the bottom of the sample 
chamber. We do not pull on the merozoite directly because this force would be weak and 
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difficult to calibrate. Finally, because erythrocytes are known to behave mechanically as a 
linear spring in this regime32, the merozoite-erythrocyte adhesive forces were calculated by 
multiplying the erythrocyte end-to-end elongation before detachment and the stiffness of 
the erythrocyte cell. The experimentalist was blinded to the RBC genotype group. 
 
Characterization of RBC membrane by flow cytometry. A panel of antibodies was selected 
against the 11 antigens that have been confirmed to be or could be potentially involved in 
cell adhesion and parasite invasion. Each blood sample was diluted at 0.5% haematocrit, 
washed twice with PBS and incubated in primary mouse monoclonal antibodies for 1h at 37°C. 
Antibodies used: anti-CD35-APC (CR1, Thermofisher, 1:50); antiCD44-BRIC 222-FITC (1:100, 
IBGRL); Integrin: anti-CD49d-APC (1:50, Milteny Biotec); anti-CD55-BRIC-216-FITC (1:500, 
IBGRL); Transferrin R: anti- CD71-FITC (1:100, ThermoFisher);  Basigin: anti-CD147-FITC 
(1:100, ThermoFisher); Band3: anti-CD233-BRIC6-FITC (1:1000, IBGRL); Duffy antigen: anti-
CD234-APC (1:100, Milteny Biotec); GYPA: CD235a-BRIC 256-FITC (1:1000, IBGRL); GYPC: anti-
CD236R-BRIC10-FITC (1:1000, IBGRL). For detection of GYPB, first cells were incubated with 
an anti-GYPB (1:100, rabbit polyclonal antibody, Abcam), then washed twice with PBS and 
then incubated with a goat-anti-rabbit AlexFluor488 labelled antibody. After incubation, cells 
were washed twice in PBS and analyzed on a BD FACS Canto flow cytometer. Data were 
analyzed using FlowJo Software (Treestar, Ashland, Oregon). Statistical analyses to test 
differences in RBC membrane surface expression across genotype groups were performed 
using R statistical software (version 3.3.3).  
 
Erythrocyte plasma membrane profiling. Plasma membrane profiling was performed as 
previously described13. Briefly, three of each Dantu genotype RBC samples were washed with 
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PBS. Surface sialic acid residues were oxidized with sodium meta-periodate (Thermo) then 
biotinylated with aminooxy-biotin (Biotium). After quenching, cells were incubated in 1% 
Triton X-100 lysis buffer. Biotinylated glycoproteins were enriched with high affinity 
streptavidin agarose beads (Pierce) and washed extensively. Captured protein was denatured 
with DTT, alkylated with iodoacetamide (IAA, Sigma) and digested on-bead with trypsin 
(Promega) in 200 mM HEPES pH 8.5 for 3h. Tryptic peptides were collected and labelled using 
TMT reagents. The reaction was quenched with hydroxylamine, and TMT-labelled samples 
combined in a 1:1:1:1:1:1:1:1:1 ratio. Labelled peptides were enriched, desalted, and 80% of 
the combined sample separated into twelve fractions using high pH reversed phase HPLC as 
previously described33. 100% of six fractions in addition to 50% of the remaining 
unfractionated sample were subjected to mass spectrometry. 
 
Mass spectrometry data were acquired using an Orbitrap Fusion Lumos (Thermo Fisher 
Scientific, San Jose, CA) interfaced via an EASYspray source to an Ultimate 3000 RSLC nano 
UHPLC. Peptides were loaded onto a 100 µm ID x 2 cm Acclaim PepMap nanoViper precolumn 
(Thermo Fisher Scientific) and resolved using a 75 µm ID x 50 cm 2 µm particle PepMap RSLC 
C18 EASYspray column. Loading solvent was 0.1% FA, analytical solvent A: 0.1% FA and B: 80% 
MeCN + 0.1% FA. All separations were carried out at 40°C. Samples were loaded at 5 
µL/minute for 5 minutes in loading solvent before beginning the analytical gradient. The 
following gradient was used: 3-7% solvent B over 2 minutes, 7-37% solvent B over 173 
minutes, followed by a 4 minute wash at 95% solvent B and equilibration at 3% solvent B for 
15 minutes. Each analysis used a MultiNotch MS3-based TMT method34. The following 
settings were used: MS1: 380-1500 Th, 120,000 Resolution, 2x105 automatic gain control 
(AGC) target, 50 ms maximum injection time. MS2: Quadrupole isolation at an isolation width 
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of m/z 0.7, CID fragmentation (normalised collision energy (NCE) 35) with ion trap scanning 
in turbo mode from m/z 120, 1.5x104 AGC target, 120 ms maximum injection time. MS3: In 
Synchronous Precursor Selection mode the top 10 MS2 ions were selected for HCD 
fragmentation (NCE 65) and scanned in the Orbitrap at 60,000 resolution with an AGC target 
of 1x105 and a maximum accumulation time of 150 ms. Ions were not accumulated for all 
parallelisable time. The entire MS/MS/MS cycle had a target time of 3 s. Dynamic exclusion 
was set to +/- 10 ppm for 70 s. MS2 fragmentation was triggered on precursors 5x103 counts 
and above. 
 
Mass spectrometry data analysis. Mass spectra were processed using a Sequest-based 
software pipeline for quantitative proteomics, “MassPike”, through a collaborative 
arrangement with Professor Steven Gygi’s laboratory at Harvard Medical School. MS spectra 
were converted to mzXML using an extractor built upon Thermo Fisher’s RAW File Reader 
library (version 4.0.26). In this extractor, the standard mzxml format has been augmented 
with additional custom fields that are specific to ion trap and Orbitrap mass spectrometry and 
essential for TMT quantitation. These additional fields include ion injection times for each 
scan, Fourier Transform-derived baseline and noise values calculated for every Orbitrap scan, 
isolation widths for each scan type, scan event numbers, and elapsed scan times. This 
software is a component of the MassPike software platform and is licensed by Harvard 
Medical School. 
 
A combined database was constructed from the human Uniprot database (26th January, 
2017) and common contaminants such as porcine trypsin and endoproteinase LysC. The 
combined database was concatenated with a reverse database composed of all protein 
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sequences in reversed order. Searches were performed using a 20 ppm precursor ion 
tolerance. Fragment ion tolerance was set to 1.0 Th. TMT tags on lysine residues and peptide 
N termini (229.162932 Da) and carbamidomethylation of cysteine residues (57.02146 Da) 
were set as static modifications, while oxidation of methionine residues (15.99492 Da) was 
set as a variable modification. 
 
To control the fraction of erroneous protein identifications, a target-decoy strategy was 
employed37. Peptide spectral matches (PSMs) were filtered to an initial peptide-level false 
discovery rate (FDR) of 1% with subsequent filtering to attain a final protein-level FDR of 1%. 
PSM filtering was performed using a linear discriminant analysis, as described previously35. 
This distinguishes correct from incorrect peptide IDs in a manner analogous to the widely 
used Percolator algorithm (https://noble.gs.washington.edu/proj/percolator/), though 
employing a distinct machine learning algorithm. The following parameters were considered: 
XCorr, ΔCn, missed cleavages, peptide length, charge state, and precursor mass accuracy. 
 
Protein assembly was guided by principles of parsimony to produce the smallest set of 
proteins necessary to account for all observed peptides (algorithm described in35. Proteins 
were quantified by summing TMT reporter ion counts across all matching peptide-spectral 
matches using “MassPike”, as described previously34. Briefly, a 0.003 Th window around the 
theoretical m/z of each reporter ion (126, 127n, 127c, 128n, 128c, 129n, 129c, 130n, 130c, 
131n, 131c) was scanned for ions, and the maximum intensity nearest to the theoretical m/z 
was used. The primary determinant of quantitation quality is the number of TMT reporter 
ions detected in each MS3 spectrum, which is directly proportional to the signal-to-noise (S:N) 
ratio observed for each ion. Conservatively, every individual peptide used for quantitation 
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was required to contribute sufficient TMT reporter ions (minimum of ~1250 per spectrum) so 
that each on its own could be expected to provide a representative picture of relative protein 
abundance34. An isolation specificity filter with a cutoff of 50% was additionally employed to 
minimise peptide co-isolation34. Peptide-spectral matches with poor quality MS3 spectra 
(more than 8 TMT channels missing and/or a combined S:N ratio of less than 250 across all 
TMT reporter ions) or no MS3 spectra at all were excluded from quantitation. Peptides 
meeting the stated criteria for reliable quantitation were then summed by parent protein, in 
effect weighting the contributions of individual peptides to the total protein signal based on 
their individual TMT reporter ion yields. Protein quantitation values were exported for further 
analysis in Excel. 
 
Proteins were filtered to include those most likely to be present at the cell surface with high 
confidence. These comprised proteins with Uniprot Subcellular Location (www.uniprot.org) 
terms matching ‘Multipass’, ‘GPI anchored’, ‘Lipid Anchored’, ‘Type I transmembrane’, ‘Type 
II transmembrane’, ‘Type III transmembrane’, ‘Type IV transmembrane’, and those predicted 
to have transmembrane regions based on TMHMM version 2.036. 
  
For protein quantitation, reverse and contaminant proteins were removed. Despite extensive 
washing of biotinylated proteins when bound to Streptavidin beads, variable levels of 
contamination with abundant haemoglobin components were nevertheless detectable. As 
opposed to normalisation assuming equal protein loading across all channels, normalisation 
was instead performed from the summed signal:noise values of all proteins passing the filter 
described above. For further analysis and display in figures, only these filtered proteins are 
displayed. For Fig. 2c and Extended Data Fig. 4b, fractional TMT signals were used (i.e. 
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reporting the fraction of maximal signal observed for each protein in each TMT channel). For 
Fig. 2b, fold change was calculated on the basis of (average signal:noise (Dantu homozygote) 
/ average signal:noise (non-Dantu). For figure Extended Data Fig. 4a, fold change was 
calculated for each Dantu variant donor by (signal:noise (Dantu homozygote) / average 
signal:noise (non-Dantu). 
 
For Fig. 2b, the method of significance A was used to estimate the p-value that each protein 
ratio was significantly different to 1. Values were calculated and corrected for multiple 
hypothesis testing using the method of Benjamini-Hochberg in Perseus version 1.5.1.637. For 
Extended Data Fig. 4b, two-tailed Student’s t-test values were calculated and corrected for 
multiple hypothesis testing using the method of Benjamini-Hochberg in Excel. Hierarchical 
centroid clustering based on uncentered correlation was performed using Cluster 3.0 
(Stanford University) and visualised using Java Treeview (http://jtreeview.sourceforge.net). 
 
RBC membrane contour detection and flickering spectrometry. Dantu and non-Dantu RBCs 
were diluted into culture medium at 0.01% Hct and loaded in different chambers to provide 
an optimal cell density and avoid overlapping cells. All live-cell experiments were performed 
at 37°C by using the setup described above. 20 second time-lapse videos were recorded at 
high frame rate (514 frames/s) and short exposure time (0.8 ms). The RBC contour was 
detected in brightfield for each frame with subpixel resolution by an optimised algorithm 
developed in house and implemented in Matlab (The MathWorks, Natick, MA), as described 
previously17 and in Supplementary Section S1. Full details of membrane fluctuation analysis 
are given in Supplementary Section S2. Briefly, the equatorial contour was decomposed into 
fluctuation modes by Fourier transforming to give a fluctuation power spectrum of mean 
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square mode amplitudes at the cell equator 〈"ℎ#"!, $ = 0$"
2〉 as a function of mode 
wavevector (&!). From these data, the bending modulus (') and tension (σ) can be fitted using 
the following equation: 









,	,                                          (1) 
where .+ is the Boltzmann constant, T is temperature, and L is mean circumference of the 
RBC contour. This equation derives from the energy of deforming a flat sheet38, and is a good 
description of shape fluctuations of the cell’s equator only in a limited range of modes. We 
show in Extended Data Fig. 10a, through the calculus of the residues, that mode between 8 
and 20 are well described by Eq. 1. Lower modes fail due to the closed shape of a cell, whereas 
higher modes fail due to optical and temporal resolution.  This model considers fluctuations 
as having thermal origin.  Eq. 1 has limiting behaviours as shown in a representative 
fluctuation power spectrum in Supplementary Section S2: the tension term (q-1 behavior) 
dominates at low modes while the bending modulus term (q-3 trend) dominates at high 
modes of the spectrum. In the range 8-20, for the parameters of RBCs, both terms contribute 
to Eq.1 and so both can be resolved robustly and independently, as demonstrated in 
Extended Data Figs. 5 and 9. The viscosity of RBCs was quantified by measuring the dynamics 
of the membrane fluctuations and their relaxation time for modes 7-11 (Supplementary 
Section S2, Extended Data Fig. 10b). This is a further independent check confirming the static 
study is measuring reliable values of tension (Extended Data Fig. 10c). 
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Extended Data Figure Legends:  
 
Extended Data Figure 1 | Erythrocytic cycle of malaria parasites. Illustration of the 
erythrocytic stage of the malaria parasite. (a) The merozoites undergo repeated rounds of 
asexual multiplication, progressing through ring, trophozoite and schizont stages. (1) This 
cycle starts when merozoites contact, attach and successfully invade RBCs in the circulation. 
The invasion period lasts for less than a minute and we are only able to follow the dynamics 
of such a fast event with real-time live microscopy11,28. The merozoite has a slightly ovoidal 
shape of 1 micron in diameter and is adapted for invasion of erythrocytes. The apical end of 
the parasite contains secretory organelles called rhoptries and micronemes that release 
proteins for helping merozoite's internalisation. In the host red cell, the parasite develops and 
multiplies, digesting haemoglobin, protected from immune attack. In the case of Plasmodium 
falciparum, the erythrocytic cycle lasts about 48 hours, and infected cells progress from (2) 
the ring stage (first 16 hours) throughout (3) trophozoite stage (around 16-36 hours) and, 
finally to (4) the schizont phase (lasts a few hours). The infected schizont then ruptures (5) 
releasing 15-30 daughter merozoites ready to infect new nearby red cells. In each cycle, less 
than 10% of parasites develop into the sexual form of the parasite called gametocytes (6). (b) 
Detailed illustration of the parasite invasion process into the red blood cell (1) described 
further in the Materials and Methods, involving the “pre-invasion” phase (contact, merozoite 
reorientation which triggers RBC membrane deformation, and tight attachment of the 
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merozoite to the RBC membrane), the “invasion” phase (initiation of invasion, penetration, 
complete internalization of the merozoite, and resealing of the RBC membrane), and the 
echinocytosis phase (formation of echinocyte). Icons adapted from ©biorender.com 
 
Extended Data Figure 2 | Invasion process across Dantu genotype groups studied by time-
lapse video microscopy. (a) RBC detachment force from a merozoite was measured using 
optical tweezers across genotype groups. RBCs attached to merozoites were pulled using 
optical traps, and the adhesive forces at the merozoite-RBC interface were quantified by 
evaluating the elastic morphological response of the RBC as it resisted merozoite detachment. 
Mean and standard deviation (SD) in Supplementary Table 3. Six biologically independent 
samples per genotype group were tested obtaining 21 events for non-Dantu, 19 for Dantu 
heterozygote, and 24 for Dantu homozygote. Importantly, the experimentalist was blinded to 
the RBC genotype group. The median is indicated by the middle red line in the boxplots, with 
the 25th and 75th percentiles indicated by the tops and bottoms of each plot, while whiskers 
denote total data range. If the median is not centered in the box, it shows sample skewness. 
Pairwise comparisons between genotype groups were performed using the two-sided Mann-
Whitney U test. (b) The degree to which merozoites deformed RBCs during invasion was given 
by a simplified four-point deformation scale (0, 1, 2, and 3), based on the most extreme 
degree of deformation achieved (Weiss et al., PLoS Pathog 2015). The degree of deformation 
was compared across genotype groups with no significant difference noticed, and between 
successful and failed invasions. The percentage of RBCs undergoing strong deformations 
(score 2/3) is significantly higher in case of successful invasions, while RBCs that were 
contacted but not invaded experience weak deformations (score 0/1). Data from 155 cells for 
non-Dantu, 191 for Dantu heterozygote, and 233 for Dantu homozygote. Number of 
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successfully invaded cells: 53 for non-Dantu, 43 for Dantu heterozygote, and 41 for Dantu-
homozygote. The visual assessment was done with blinded data by two different 
experimentalists. (c) Successful invasions are usually followed by a reversible echinocyte 
phase that lasts between 5 and 11 minutes (Gilson and Crabb, Int J Parasitol, 2009), until the 
recovery of newly infected RBC biconcave shape. The time of echinocytosis was in agreement 
with literature and not significantly different across genotype groups. Data from 53 cells non-
Dantu, 43 Dantu heterozygote, and 41 Dantu-homozygote. 
 
Extended Data Figure 3 | Distribution of reticulocytes and RNA concentrations across Dantu 
genotypes. Reticulocyte counts, and concentrations of RNA extracted from reticulocytes, 
were compared across Dantu genotypes. Reticulocyte count data was tested for 8 non-Dantu, 
7 Dantu heterozygotes and 7 Dantu homozygote individuals, while RNA concentrations were 
measured in 9 non-Dantu, 7 Dantu heterozygotes and 7 Dantu homozygote individuals. The 
median is indicated by the middle red line in the boxplots, with the 25th and 75th percentiles 
indicated by the tops and bottoms of each plot, while whiskers denote total data range. 
 Statistical comparison across the three genotype groups was performed using a one-way 
ANOVA test, while all pairwise comparisons between genotype groups were performed using 
the Tukey HSD test correcting for multiple pairwise comparison tests using Benjamini-
Hochberg FDR. Significant differences were observed in reticulocyte count (non-Dantu vs. 
Dantu homozygote p=0.0023) and RNA concentrations (non-Dantu vs. Dantu homozygote 
p=0.0015; non-Dantu vs. Dantu heterozygote p=0.0088). ** p < 0.01; * p < 0.05. 
 
Extended Data Figure 4 | Plasma membrane profiling by tandem mass tag (TMT)-based MS3 
mass spectrometry. The impact of the Dantu polymorphism on RBC membrane protein 
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expression levels was quantified using mass spectrometry. (a) Hierarchical cluster analysis of 
all proteins quantified and annotated as described in the Methods. Fold change was 
calculated for each donor by (signal:noise (donor) / average signal:noise (non-Dantu). (b) 
Proteomic quantification of markers shown in Figure 2a (3 biologically independent samples 
per genotype group). All markers were quantified by proteomics apart from GYPB. Statistical 
comparisons of quantitative protein expression across Dantu genotype groups were 
performed using two-tailed t-test with Benjamini-Hochberg multiple hypothesis correction: * 
p< 0.05, **p< 0.01. All p-values are listed in Supplementary Table 4. 
 
Extended Data Figure 5 | Representative membrane fluctuation spectra for non-Dantu, 
Dantu heterozygous, and Dantu homozygous red blood cells. Example of contour detection 
and flickering spectra across genotype groups. (a) Contour of the RBC (dashed blue line), with 
inner and outer bounds used in image analysis (green lines). (b) Contour of the RBC. (c) Mean 
square fluctuation amplitudes for non-Dantu (green line), Dantu heterozygote (orange line), 
and Dantu homozygote (purple line) RBCs. Fitted modes 8-20. 
The error bars (not shown for clarity) were calculated as /0/2(4 × 67)	, where SD is the 
standard deviation, n total number of frames, and dt the time gap between frames. 
 
Extended Data Figure 6 | Relationship between biophysical properties in non-Dantu and 
Dantu homozygote RBCs. (a) Scatter plot showing correlation between tension and radius in 
non-Dantu and Dantu homozygote RBCs. The shaded points in the background are all the data 
considered for non-Dantu (249) and Dantu (247) RBCs from six different biological replicates. 
The big marks in the foreground represent the mean and standard deviation in tension and 
radius of the six samples for non-Dantu and Dantu RBCs. There is a linear inverse relation 
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between radius and tension, where we observe that RBCs with higher tension have lower 
radii. Radius change is very small (0.3 μm) and, we believe, equatorial radius decrease is due 
to a shape change caused by the increased tension, and the two biophysical parameters have 
no different fluctuation modes. (b) The impact of tension on RBC deformation during pre-
invasion, induced by merozoites contacting RBCs, was compared across Dantu genotype 
groups. RBCs having tension above the tension threshold tended to be weakly deformed 
(scores 0 and 1), whereas RBCs with tensions below the threshold were more strongly 
deformed (scores 2 and 3). Deformation scores as defined in Weiss et al. PLoS Pathog. 2015 
(Reference 10 of the manuscript). 
 
Extended Data Figure 7 | Reduction of membrane tension both in non-Dantu and Dantu 
homozygous RBCs with phloretin. Biophysical properties in non-Dantu (a,b) and Dantu 
homozygous (c,d) RBCs after phloretin treatment **p < 0.01. Phloretin treatment causes a 
decrease in tension without affecting bending modulus at 150 (p = 0.0015) and 200 (p = 1.72 
x10-4) μM for both non-Dantu and Dantu samples. Above 200 μM concentration of phloretin, 
most RBCs become crenated and cannot be used for flickering spectroscopy. Phloretin has an 
effect on RBC tension only when it is present in the medium, i.e. RBCs recover their normal 
tension when washed.  (a-b) Data from about 30 cells from 3 biologically independent non-
Dantu samples. (c-d) Data from 60 cells from 4 biologically independent Dantu samples. 
Between untreated and phloretin 150 μM (p = 0.01) and between untreated and phloretin 
200 μM (p = 0.0022) using the two-sided Mann-Whitney U test.   
 
Extended Data Figure 8 | Comparing parasite invasion and biomechanical properties of 
frozen and fresh RBCs. 
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Comparison of parasite invasion efficiency and biomechanical properties in frozen vs fresh 
RBCs. (a) The invasion efficiency of P. falciparum laboratory strain, 3D7, was compared across 
frozen and fresh RBCs (n=6 frozen and n=14 non-Dantu, 12 Dantu heterozygote and 12 Dantu 
homozygote fresh biologically independent RBC samples per genotype group were tested). 
The percentage of parasitised RBCs that successfully invaded each genotype group was 
measured using a flow cytometry-based invasion assay. Boxplots indicate the median (middle 
line) and interquartile ranges (top and bottom of boxes) of the data, while whiskers denote 
the total data range. Statistical comparison across the three genotype groups was performed 
using a one-way ANOVA test, while pairwise comparisons between genotype groups were 
performed using the Tukey HSD test, with significant differences in 3D7 invasion observed in 
frozen RBCS (non-Dantu vs. Dantu homozygote p=0.001) and in fresh RBCs (non-Dantu vs. 
Dantu homozygote p=0.001). **p < 0.01; *p < 0.05. (b) Membrane flickering spectrometry 
enabled measurement of RBC biomechanical properties (bending modulus, tension, radius, 
and viscosity) of fresh (n = 53) and frozen (n = 51) RBCs from the same donor. No statistically 
significant differences were detected between the two conditions for all the measured 
biophysical properties. Pairwise comparisons were performed using the two-sided Mann-
Whitney U test; p Bending modulus = 0.1, p Tension = 0.6, p Radius = 0.7, p Viscosity = 0.6. 
 
Extended Data Figure 9 | Decoupling tension and bending modulus with flickering analysis. 
To test our ability to decouple tension and bending modulus from our data through the 
flickering analysis, we have taken the 20 highest tension and the 20 lowest tension cells from 
our database and shown that on analysing the fluctuation power spectra of these, which 
cover a wide enough range of q-values that both tension and bending moduli can be robustly 
extracted. (a-b) Boxplots for the tensions and bending moduli of the 20 cells with extreme 
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high and extreme low tensions. While there is an obvious significant difference in tension 
(p=4.0302 x 10-13, two-sided Mann-Whitney U test), bending modulus is similar. (c) This is also 
evident from the overlapping of the two spectra for the high modes where a bending-
dominated regime prevails, whereas the divergence of the fluctuation amplitudes between 
the two spectra becomes noticeable when tension predominates. Each mean-square 
fluctuation spectrum is obtained averaging all 20 fluctuation spectra for both low (blue) and 
high (yellow) tension cells. Since tension dominates low modes (q-1 behavior) and bending 
modulus dominates high modes of the spectra (q-3 trend), the decoupling between tension 
and bending modulus becomes evident from these two spectra (Extended Data Section S2). 
 
Extended Data Figure 10 | Membrane flickering spectroscopy amplitude analysis. (a) To 
justify our choice of modes for fitting Eq. S4, we calculated the residuals of mean square 
fluctuation amplitudes at different ranges of modes for the same RBC. The figure shows that 
the residues derived from fitting modes above 20 increase steadily, suggesting a systematic 
error in fitting modes above 20. Our range of modes (8-20) seems the most convincing range, 
as well as range 5-20, with no systematic deviations.  
By studying the dynamics of modes it is possible to extract the viscosity of the cell interior, 
and this analysis can be used as further proof of the method. From the timescale of 
decorrelation of mode amplitudes, it is possible to obtain the viscosity of the RBC interior, 
using the values of tension and bending modulus obtained from the static spectrum of the 
same cell. This is achieved by fitting the relaxation time with Eq. S7. The viscosity is statistically 
the same, across the non-Dantu and Dantu groups which have statistically different tension 
values. This is thus a further independent check confirming the static study is measuring 
tension values reliably. (b) The viscosities of RBCs with extreme low and high tension are not 
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significantly different (p value=0.14, two-sided Mann-Whitney U test). The fit in the inset 
shows data from one of the RBCs in the sample. (c) The relaxation times, plotted vs qx, modes 
5-11, are represented for both the low- and high-tension RBCs; the trend is 1/q consistent 
with the limiting behaviour of Eq. S7 for (9 ≫ '&!&). The range of modes that can be studied 
dynamically is limited by the camera acquisition rate, as well as by the other factors that limit 

































Table 1 | Clinical and demographic characteristics of study participants 
 
  Pairwise comparisons between 
genotype groups 

































11.4 (1.6) 11.6 (1.7) 9.3 (4.1) - 0.3671 0.1498 0.1704 
Sex (F/M) 5/10 5/9 5/8 - 0.4557 0.9064 0.5127 
Red blood cell 
count (SD; 
106/µL) 




0.02 (0.01) 0.04 (0.01) 0.05 (0.02) 0.545 0.4451 0.4539 0.2906 
White blood 
cell count (SD; 
103/µL) 





293.31 (73.91) 346.92 
(96.40) 






























33.81 (0.63) 33.33 (1.51) 0.113 0.2774 0.0986 0.0622 
Red blood cell 
distribution 
width (SD; %) 
12.83 
(1.29) 
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S1: Theoretical basis of membrane flickering spectroscopy 
 
Flickering spectroscopy is a technique that allows the extraction of information about the mechanical 
properties of a fluctuating membrane through an analysis of its thermal fluctuations. 
The classical derivation of the membrane fluctuation spectrum as formulated by Helfrich et al.1 is valid for 
small fluctuations in a quasi-planar approximation, assuming fluctuations are of thermal origin2,3,4,5,9. The 
expression for the elastic energy E  required to deform a flat membrane to a shape given by h(x,y), when 
resisted by  a membrane tension and a bending modulus, is 
 
! = !"∫ "#"$ #%(∇




	 	,                                                   (S.1) 
 
where σ is the tension, κ the bending modulus, and ℎ(0, 1) the height of the membrane with respect to a 
fixed horizontal plane in the point of coordinates (0, 1). Membrane tension is defined as the resistance 
to stretch and in a red blood cell it is primarily provided by the cytoskeleton and by osmotic pressure. 
Bending modulus is an intrinsic property of the membrane, related to the amount of energy required to 
bend it; it is affected by lipid composition, membrane thickness, cytoskeleton, membrane asymmetry, but 
not by osmotic pressure.  
If the membrane considered is squared with dimension 2 × 2 and with periodic boundary conditions it is 
possible to expand ℎ(0, 1)	using Fourier series and, following6, to obtain 
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where the wavevectors q are (qx + qy)½, with qx and qy as usual in the set 2pi/L*i, i=1:inf. This expression 
shows that a fluctuation mode will cost either more bending or more stretching energy depending on the 
wave vector: for small wave vectors, i.e. large length scales, the energy cost will be mainly due to 
stretching and for bigger wave vectors bending will dominate instead. Using the equipartition theorem, 
the mean square amplitude of each mode can be related to the bending modulus and tension by 
 
〈|ℎ(7$⃗ )|2〉 = (!)*2(,-4+/-2).                                                                         (S.3) 
 
The angular brackets denote an ensemble average (in experiments, a time average), 81	the Boltzmann’s 
constant and 9 the absolute temperature. Equation S.3 is the expression for the fluctuation spectrum of 
the membrane, hence, the mean square amplitude of the modes depends on the thermal energy and on 
the membrane properties. This quantity is central for the flickering spectroscopy analysis which consists 
in measuring the mean square amplitude of the modes of a fluctuating membrane and then fitting the 
experimental spectrum with equation S.3 to obtain tension and bending modulus. 
 
Pecreaux et al.7 demonstrated that the planar approximation can still be adapted in the case of closed 
objects such vesicles, where only the fluctuations of the cell in the plane of its equator (y=0) are 
considered. The resulting contour fluctuations can be calculated by an inverse Fourier-transform over 72 
of Eq. S.3, evaluated for 1 = 0: 
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A red blood cell membrane is much more complex than a simple phospholipid bilayer and its fluctuations 
could be considered as constrained by the spectrin skeleton10. This can be addressed with a tethering 
parameter -that links lipids to cytoskeleton, and in this case, the expression of the fluctuations is2 
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where - is the constraining term or elastic restoring force.  
We discuss below the range of modes that can be addressed experimentally, which is the most important 
limitation of this approach. An alternative experimental technique of beam deflection, Betz et al.8,11 has 
suggested an ATP-dependent mechanics of red blood cells, but this has not been confirmed in other 
contour flickering experiments4,5,9 and thus we believe that it is appropriate to analyse the equatorial 
fluctuations of RBCs using equations S.4 and S.5. 
 
S2: Membrane contour detection algorithm and flickering amplitude analysis 
 
The flickering method relies on image analysis of detailed shapes of the RBC. In particular, the equatorial 
profile can be detected very accurately with sub-pixel resolution from digital video recordings, and 
analysed automatically as published in previous works2.  
Each cell was recorded in bright field for 10000 frames at 514 frames/s with 0.8 ms of exposure time. The 
exposure time was set as short as possible to increase the range of modes that can be analysed; in fact 
modes with a lifetime shorter than the exposure time will be integrated and therefore not be considered. 
From each digital frame, we extracted the resulting radial profile C(D), where C is the radius of the cell 
equator and 7 is the azimuthal angle (from 0 to 360 degrees). The information from the whole image 
stack is analysed to determine mechanical and dynamical parameters of the cell, as described below and 
in Yoon et al. These profiles are then Fourier transformed and the mean square amplitude of each Fourier 
mode is calculated. This amplitude can be fitted to Eq. S.5, which is derived from the theory of fluctuations 
described above. In our data, we do not see an effect of gamma, whereas sigma and kappa can be robustly 
fitted. The amplitudes of very low modes <5 (large wavelength) are excluded because they are affected 
by the geometry of the surface and because the deviation from the exact spherical harmonics expression 
becomes significant. Very high modes (> 20) are affected by noise and their fluctuations lie outside the 
spatial and temporal resolution of the experiment. This is validated in Fig.S15. We thus considered modes 
8 to 20 for fitting to the theory. Examples of our spectra are reported in Supplementary Fig. 9. 
Eq. S.4 has two limiting behaviours: 〈ℎ)73, 1 = 0*
2〉~7−1 for low modes, if dominated by tension (? ≫
=77"); Instead, at large q, there is a bending-dominated regime 〈ℎ)73, 1 = 0*
2〉~7−3	 for (σ≪ 9732). In 
the range we consider, which is the whole experimentally accessible range, both terms are contributing 
to the deformation energy, and the slope is an intermediate power law. This is fortunate, because it means 
that this approach is able to address both tension and bending, for red blood cells.  
 
The dynamics of the fluctuations can also be quantified2. We calculated the autocorrelation function of 
the modes, averaged over 10000 frames. This analysis works well on modes 7 to 11, but higher modes 
decay too fast to be fitted. The range of modes that can be studied dynamically is limited by the camera 
acquisition rate, as well as by the other factors that limit also the static analysis.  
 
The time correlation function of spatial modes is an exponential decay: 
 
G	-#⃗ 	(H) = 〈ℎ(7$⃗ , H′), ℎ)7$⃗ , H′ + H*〉:′	,	                                            (S.6) 
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Equation S.7 gives the relaxation timescale of the modes of a two-dimensional membrane, as a function 
of the wave vectors. In Eq. S.7, ;B is the two-dimensional membrane viscosity, ;CDEand ;F7E are the 
viscosities of the fluid on either side of the membrane, R is the radius of the cell membrane. Two-
dimensional phospholipid bilayers have viscosities ;B <10−9 N s m−1 for temperatures above room T, and 
;F7E ≅ 10−3 Pa s, therefore ;CDE dominates the denominator of expression S.7, i.e. we are able to measure 
from this procedure the internal viscosity of the RBC. Finally, from  :-#⃗ , using the values of 9 and < obtained 
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MSC1 GG AA Het CC AA AG DI 
MSC2 AG AA Norm CT AA AA DD 
MSC3 AA AA Norm CC AA AG DD 
MSC4 GG AA Norm TT AG AG II 
MSC5 AG AA Norm CC AA AG DD 
MSC6 AA AA Norm CC AA - - 
MSC7 GG AA Norm - - - - 
MSC8 AG AA Norm CC AA AG DD 
MSC9 AA AA Norm CC AA GG DI 
MSC 10 GG AA Het - - - - 
MSC 11 AG AA Het CC AA AG DD 
MSC 12 AA AA Norm TT AA - - 
MSC 13 GG AA Het - - - - 
MSC 14 AG AA Het TT AA GG DI 
MSC 15 AA AA Norm CC AA GG DI 
MSC 16 GG - - - - - - 
MSC 17 AG AA Het CT AA AG DI 
MSC 18 AA AA Norm CC AA AG DD 
KBC1 GG AA Norm CC AA GG DI 
KBC2 AA AA Norm CC AA GG DI 
KBC3 AG AA Norm CC AA GG DI 
KBC4 GG AA Norm CC GG AG DD 
KBC5 AA AA Norm CC GG AG DD 
KBC6 AA AA Norm CC AA GG DD 
KBC7 GG AA Norm CC AA GG DD 
KBC 8 AG AA Norm CC AA GG DD 
KBC 9 AG AA Norm CC AG GG DI 
KBC 10 GG AA Norm CC AG GG DI 
KBC 11 AA AA Norm CC AG GG DI 
KBC 12 AG AA Norm CC AA AG DD 
KBC 13 GG AA Norm CC AA AG DD 
KBC 14 AA AA Norm CC AA AG DD 
KBC 15 AG AA Norm CC AA GG DI 
KBC 16 AA AA Norm CC AA GG II 
KBC 17 GG AA Norm CC AA GG II 
KBC 18 AA AA Norm CC AG GG DD 
KBC 19 AG AA Norm CC AG GG DD 
KBC 20 GG AA Norm CC AG GG DD 
KBC 21 AA AA Norm CC AA GG DI 
KBC 22 AG AA Norm CC GG AG DI 
KBC 23 AA AA Norm CC GG AG DI 
KBC 24 AG AA Norm CC AA GG II 
 
Study participant genotype information for malaria-protective polymorphisms including Dantu (rs186873296), HBB 
(rs334), alpha-thalassaemia, G6PD (rs1050828), ATP2B4 (rs1541255) and CR1 (rs17047661), and ABO (rs8176719). 
Study subjects were obtained from two cohorts, from which both frozen and fresh red blood cell (RBC) samples were 
obtained. Genotypes were controlled within each experimental set of Dantu homozygous protective genotype 
(rs186873296=GG), heterozygote protective genotype (rs186873296=AG), and non-Dantu (rs186873296=AA) 
individuals. 
The definition of all other genotypes is as follows:  
HBB - rs334: AA-non-sickle; AS-sickle cell trait; SS-sickle cell disease 
Alpha-thalassaemia: Norm-homozygous reference genotype; Het-heterozygous protective genotype; Hom- 
homozygous protective genotype  
G6PD - rs1050828: CC-homozygous reference genotype; CT-heterozygous protective genotype; TT-homozygous 
protective genotype 
ATP2B4 - rs1541255: AA-homozygous reference genotype; AG-heterozygous protective genotype; GG-homozygous 
protective genotype 
CR1 - rs17047661:  GG-homozygous reference genotype; AG-heterozygous protective genotype; AA-homozygous 
protective genotype 






































Dantu hom (%) 
P adj non-Dantu-
Dantu het (%) 
P adj Dantu het-
Dantu hom (%) 
P adj 







0.114 1.1565 (-0.0019 
- 2.3149) 
0.050 
Dd2 0.018 2.7888 (0.535 - 
5.0426) 
0.015 * 1.012 (-1.2418 
- 3.2658) 
0.490 1.7768 (-0.477 - 
4.0306) 
0.135 
SAO75 0.035 2.0798 (0.212 - 
3.9476) 
0.028 * 0.8854 (-
0.9824 - 
2.7532) 
0.454 1.1945 (-0.6733 
- 3.0623) 
0.252 
GB4 0.122 0.6852 (-1.6704 - 
3.0408) 
0.719 1.8461 (-
0.3747 - 4.067) 
0.107 1.1609 (-1.1947 
- 3.5166) 
0.961 





0.186 0.948 (-1.7681 - 
3.6641) 
0.967 
ΔPfEBA175 0.028 1.3932 (0.056 - 
2.7303) 
0.040 * 1.2441 (-0.093 
- 2.5813) 




Mean difference in parasitaemia between Dantu genotype groups (n=6 biologically independent samples per 
genotype group) is compared using the one-way ANOVA, and pairwise comparisons with p-values adjusted for 
multiple comparisons (P adj) using Tukey HSD test. The lower and upper limits of the differences in parasitaemia are 




















Supplementary Table 3 | Merozoite-RBC adhesion force measured by optical tweezers 
 
 Non-Dantu  
(Mean ± SD) 
Dantu heterozygote 
(Mean ± SD) 
Dantu homozygote 
(Mean ± SD) 
Number of cells 19 21 24 
Merozoite-erythrocyte 
attachment force 
42.5 ± 15.7 49.5 ± 22.9 39.8 ± 15.6 
 
Adhesive forces between merozoites and RBCs during invasion were measured using optical tweezers, as explained 
in detail in the Methods. Mean and standard deviation (SD) of data in Supplementary Fig. 3 for the three genotype 
groups are shown.
Supplementary Table 4 | Proteomic data from plasma membrane profiling by tandem mass tag (TMT)-based MS3 
mass spectrometry  
 

































Q86UD5 Mitochondrial sodium/hydrogen exchanger 
9B2 
SLC9B2 1 24 32 33 161 277 137 522 587 573 18.81 8.17E-11 
P15529-2 Membrane cofactor protein CD46 2 61 64 87 208 246 1176 401 580 1248 10.53 2.49E-07 
Q9H015 Solute carrier family 22 member 4 SLC22A4 7 130 139 211 111 251 8007 135 1031 2769 8.20 4.62E-06 
P02786 Transferrin receptor protein 1 CD71 21 1506 1772 1215 12127 4928 3092 10872 3846 14571 6.52 5.12E-05 
O95980 Reversion-inducing cysteine-rich protein with 
Kazal motifs 
RECK 5 290 383 278 541 431 477 815 3893 375 5.35 3.27E-04 
P54709 Sodium/potassium-transporting ATPase 
subunit beta-3 
ATP1B3 7 937 402 350 1004 2463 1130 3271 2886 2392 5.06 5.29E-04 
Q01650 Large neutral amino acids transporter small 
subunit 1 
SLC7A5 1 23 26 21 71 83 37 86 47 212 4.87 7.34E-04 
Q9P0T7 Transmembrane protein 9 TMEM9 6 620 619 967 795 1039 692 5185 2588 2846 4.81 8.10E-04 
Q03252 Lamin-B2 LMNB2 2 147 145 124 170 151 122 762 924 159 4.43 1.59E-03 
P05026 Sodium/potassium-transporting ATPase 
subunit beta-1 
ATP1B1 13 1257 1233 1089 6314 4911 3390 5396 3427 4592 3.75 5.56E-03 
P48029 Sodium- and chloride-dependent creatine 
transporter 1 
SLC6A8 8 291 440 415 222 309 2695 282 1115 2773 3.64 6.83E-03 
P16671 Platelet glycoprotein 4 CD36 9 1315 1453 1177 1460 1676 2507 2954 5583 5366 3.52 8.56E-03 
Q8WUY1 Protein THEM6 THEM6 2 114 146 108 289 222 169 476 358 456 3.51 8.83E-03 
P14209 CD99 antigen CD99 20 1402 2861 1462 917 4176 955 10207 4534 4667 3.39 1.11E-02 
O14662 Syntaxin-16 STX16 1 172 99 110 81 96 90 123 136 1000 3.31 1.30E-02 
Q9H8M5 Metal transporter CNNM2 CNNM2 4 289 279 278 323 288 392 747 845 963 3.02 2.30E-02 
P06213 Insulin receptor INSR 15 2239 1988 1773 3039 3840 4078 5552 7108 5261 2.99 2.46E-02 
Q9HD45 Transmembrane 9 superfamily member 3 TM9SF3 3 98 132 143 101 230 83 303 496 276 2.88 3.04E-02 
Q13444 Disintegrin and metalloproteinase domain-
containing protein 15 
ADAM15 1 23 25 38 31 325 36 47 157 37 2.83 3.36E-02 
P05556 Integrin beta-1 ITGB1 7 918 937 900 1020 1072 4140 1465 2493 3781 2.81 3.52E-02 
Q08174-2 Protocadherin-1 PCDH1 20 2608 1791 1979 1845 2586 2086 10384 4459 2946 2.79 3.67E-02 
Q9Y289 Sodium-dependent multivitamin transporter SLC5A6 1 36 37 40 23 38 251 39 95 164 2.65 4.83E-02 
P08069 Insulin-like growth factor 1 receptor IGF1R 8 826 728 803 1408 1487 1664 1664 2534 1749 2.52 6.33E-02 
Q15758 Neutral amino acid transporter B(0) SLC1A5 2 225 293 322 379 481 375 609 542 930 2.48 6.92E-02 
P18433 Receptor-type tyrosine-protein phosphatase 
alpha 
PTPRA 31 5021 5172 3199 6103 8167 5916 14135 11403 7259 2.45 7.36E-02 
P31995 Low affinity immunoglobulin gamma Fc region 
receptor II-c 
FCGR2C 1 142 63 126 108 102 134 432 218 135 2.38 8.57E-02 
P54852 Epithelial membrane protein 3 EMP3 4 743 877 926 1153 1468 2069 1656 2038 2055 2.26 1.09E-01 
P60903 Protein S100-A10 S100A10 3 725 584 118 419 132 72 1326 1681 112 2.19 1.27E-01 
Q53GQ0 Estradiol 17-beta-dehydrogenase 12 HSD17B12 6 605 610 570 945 769 766 2061 1096 649 2.13 1.42E-01 
P50895 Basal cell adhesion molecule BCAM 112 9406 15885 18802 8882 23703 14094 31114 34364 26310 2.08 1.57E-01 
Q9NQ34 Transmembrane protein 9B TMEM9B 5 773 655 901 902 781 785 2310 1332 1193 2.08 1.59E-01 
Q6UVK1 Chondroitin sulfate proteoglycan 4 CSPG4 1 23 36 30 23 42 25 47 53 79 2.02 1.79E-01 
Q6PCB8 Embigin EMB 2 95 203 327 324 401 133 293 323 636 2.00 1.85E-01 
Q15517 Corneodesmosin CDSN 2 781 752 634 1003 1046 1076 1503 1556 1267 2.00 1.87E-01 
O60449-2 Lymphocyte antigen 75 LY75 4 296 315 310 401 765 546 590 567 633 1.94 2.10E-01 
P08195-4 4F2 cell-surface antigen heavy chain SLC3A2 17 3047 3358 3366 5085 4857 3912 6122 4825 7889 1.93 2.16E-01 
Q7KYR7-1 Butyrophilin subfamily 2 member A1 BTN2A1 12 1617 789 1463 1821 2753 2003 2195 2229 2939 1.90 2.28E-01 
P08575 Receptor-type tyrosine-protein phosphatase C PTPRC 19 3042 2825 3022 3710 5428 6515 4608 6500 5763 1.90 2.30E-01 
Q8WUX1 Sodium-coupled neutral amino acid transporter 
5 
SLC38A5 2 441 470 495 569 520 1181 531 736 1366 1.87 2.43E-01 
P05023-4 Sodium/potassium-transporting ATPase 
subunit alpha-1 
ATP1A1 43 8216 7522 6845 11353 12872 8631 12810 10757 18474 1.86 2.48E-01 
P15151 Poliovirus receptor PVR 4 478 389 891 813 1775 1353 1221 972 1039 1.84 2.60E-01 
Q9UBI6 Guanine nucleotide-binding protein 
G(I)/G(S)/G(O) subunit gamma-12 
GNG12 1 84 86 24 28 24 21 136 142 77 1.82 2.68E-01 
Q7L1W4 Leucine-rich repeat-containing protein 8D LRRC8D 1 23 23 18 22 32 35 40 47 30 1.81 2.78E-01 
Q5T4S7-2 E3 ubiquitin-protein ligase UBR4 UBR4 135 20342 15621 14499 23262 42016 27041 37768 18978 33400 1.79 2.89E-01 
Q8IWT6 Leucine-rich repeat-containing protein 8A LRRC8A 3 198 193 167 201 281 330 284 446 265 1.79 2.90E-01 
P17813 Endoglin ENG 23 3966 4002 3131 5074 7249 6985 6155 7337 5919 1.75 3.12E-01 
Q16563 Synaptophysin-like protein 1 SYPL1 17 5090 3049 2541 5057 7314 5720 4969 6561 7070 1.74 3.16E-01 
P02724 Glycophorin-A (Shared) GYPA 
Shared 
439 57855 66296 60248 92359 71317 76464 112479 103046 105388 1.74 3.17E-01 
Q2LD37 Uncharacterized protein KIAA1109 KIAA1109 1 11 16 23 18 22 18 21 27 39 1.73 3.24E-01 
P55011 Solute carrier family 12 member 2 SLC12A2 9 1862 1571 1669 3437 3592 2632 2043 3170 3613 1.73 3.24E-01 
P61106 Ras-related protein Rab-14 RAB14 4 424 571 554 903 538 532 850 730 1074 1.71 3.36E-01 
Q12913 Receptor-type tyrosine-protein phosphatase 
eta 
PTPRJ 6 1231 1121 1044 1382 1823 1673 1723 2310 1748 1.70 3.43E-01 
Q7Z4F1 Low-density lipoprotein receptor-related 
protein 10 
LRP10 8 812 749 670 667 943 821 1738 1137 879 1.68 3.57E-01 
P08473 Neprilysin MME 2 190 195 122 162 217 167 317 330 200 1.67 3.64E-01 
P08174-7 Complement decay-accelerating factor CD55 122 21540 18780 18345 34764 20358 24121 35657 35584 24655 1.63 3.92E-01 
O60888-2 Protein CutA CUTA 1 22 24 29 40 34 36 35 49 38 1.63 3.99E-01 
Q9UP95-7 Solute carrier family 12 member 4 SLC12A4 2 282 264 359 560 466 427 557 460 451 1.62 4.02E-01 
Q9UHW9-2 Solute carrier family 12 member 6 SLC12A6 2 510 376 366 741 430 797 687 792 536 1.61 4.12E-01 
P78410 Butyrophilin subfamily 3 member A2 BTN3A2 5 519 653 693 983 1051 609 1322 900 762 1.60 4.21E-01 
Q12767-2 Uncharacterized protein KIAA0195 KIAA0195 8 669 727 787 1267 1513 1178 1119 982 1384 1.60 4.23E-01 
P15144 Aminopeptidase N ANPEP 4 537 484 191 253 194 180 684 1023 214 1.59 4.32E-01 
Q9H0X4 Protein ITFG3 ITFG3 8 1724 846 1353 1052 2737 2512 2271 2054 1880 1.58 4.36E-01 
P16070 CD44 antigen CD44 111 22570 25060 25182 20499 43940 41766 39269 29641 45652 1.57 4.43E-01 
Q99497 Protein DJ-1 PARK7 15 2133 3143 1941 5266 2859 2818 4700 2677 3907 1.56 4.52E-01 
Q16610-4 Extracellular matrix protein 1 ECM1 1 145 128 132 86 209 165 125 210 296 1.56 4.56E-01 
P14415 Sodium/potassium-transporting ATPase 
subunit beta-2 
ATP1B2 12 2877 1630 1835 1984 2937 1974 2849 2804 4083 1.54 4.78E-01 
O60486 Plexin-C1 PLXNC1 17 2926 2726 3563 3626 3379 4185 3371 4097 6294 1.49 5.18E-01 
Q8TF66-2 Leucine-rich repeat-containing protein 15 LRRC15 1 16 26 53 22 24 22 28 40 72 1.49 5.22E-01 
Q9BTV4 Transmembrane protein 43 TMEM43 1 212 167 24 44 48 27 232 309 55 1.48 5.33E-01 
Q96PL5 Erythroid membrane-associated protein ERMAP 39 8900 7660 7148 10478 9745 9720 13093 13241 8658 1.48 5.36E-01 
P11279 Lysosome-associated membrane glycoprotein 1 LAMP1 5 275 276 283 929 652 728 217 509 503 1.47 5.38E-01 
P11215-2 Integrin alpha-M ITGAM 2 68 109 202 281 134 86 87 62 407 1.46 5.47E-01 
Q96FZ7 Charged multivesicular body protein 6 CHMP6 1 268 309 224 340 273 289 371 433 352 1.44 5.70E-01 
Q9H0U4 Ras-related protein Rab-1B RAB1B 1 188 155 130 202 274 195 253 246 182 1.44 5.73E-01 
P20340-2 Ras-related protein Rab-6A RAB6A 1 72 51 34 86 84 45 69 80 76 1.44 5.73E-01 
O75396 Vesicle-trafficking protein SEC22b SEC22B 2 186 179 136 246 181 170 264 271 181 1.43 5.86E-01 
P22303-2 Acetylcholinesterase ACHE 84 16474 15624 12835 21679 15077 9986 20244 24751 18510 1.41 6.04E-01 
Q8WW22-2 DnaJ homolog subfamily A member 4 DNAJA4 5 1515 2124 1380 1865 2266 1420 2884 1846 2341 1.41 6.09E-01 
Q02161 Blood group Rh(D) polypeptide RHD 21 3324 3766 3498 5174 3384 3471 6909 4159 3743 1.40 6.20E-01 
Q4KMQ2-2 Anoctamin-6 ANO6 6 1439 2250 1578 2733 1887 2476 2696 1425 3219 1.39 6.26E-01 
O15440 Multidrug resistance-associated protein 5 ABCC5 34 7485 6139 8245 10919 10086 10682 9943 11532 8950 1.39 6.29E-01 
Q5HYA8 Meckelin TMEM67 1 69 66 82 74 120 97 33 134 134 1.38 6.38E-01 
P61026 Ras-related protein Rab-10 RAB10 4 1072 959 541 1052 1325 998 1321 1221 1017 1.38 6.38E-01 
Q9NZM1 Myoferlin MYOF 2 371 392 161 146 189 176 538 552 185 1.38 6.43E-01 
P02814 Submaxillary gland androgen-regulated protein 
3B 
SMR3B 1 25 30 33 25 29 33 47 42 32 1.37 6.54E-01 
Q15907 Ras-related protein Rab-11B RAB11B 1 192 126 58 120 131 77 127 255 133 1.37 6.56E-01 
Q96Q45-3 Transmembrane protein 237 TMEM237 6 1266 1742 1748 1811 1720 2288 1815 2383 2291 1.36 6.61E-01 
P05107 Integrin beta-2 ITGB2 3 92 131 363 497 257 196 99 114 586 1.36 6.62E-01 
Q92692 Poliovirus receptor-related protein 2 PVRL2 3 281 146 315 238 566 512 322 395 288 1.35 6.73E-01 
P16615 Sarcoplasmic/endoplasmic reticulum calcium 
ATPase 2 
ATP2A2 2 87 116 80 84 89 61 159 133 90 1.35 6.82E-01 
Q04941 Proteolipid protein 2 PLP2 3 605 826 593 814 721 1241 484 990 1253 1.35 6.82E-01 
Q9NRQ2 Phospholipid scramblase 4 PLSCR4 4 587 350 407 417 703 724 499 866 448 1.35 6.83E-01 
Q9UHW9 Solute carrier family 12 member 6 SLC12A6 23 5935 4140 4275 6608 7453 10089 5822 8315 5163 1.34 6.86E-01 
Q9Y639 Neuroplastin NPTN 23 4308 5760 5406 6457 6833 5113 6512 7458 6795 1.34 6.90E-01 
Q9UIQ6 Leucyl-cystinyl aminopeptidase LNPEP 6 841 656 659 832 848 924 876 1373 634 1.34 6.95E-01 
P54760 Ephrin type-B receptor 4 EPHB4 22 3025 3509 3705 4611 4751 4890 3322 5432 4929 1.34 6.96E-01 
O94919 Endonuclease domain-containing 1 protein ENDOD1 14 1703 2178 1302 3105 2182 1908 3046 1955 1882 1.33 7.07E-01 
Q9Y6R1-5 Electrogenic sodium bicarbonate cotransporter 
1 
SLC4A4 2 94 81 75 120 137 148 116 112 103 1.33 7.11E-01 
Q04656-3 Copper-transporting ATPase 1 ATP7A 67 13630 12557 11899 21504 18302 18286 17476 15029 17887 1.32 7.14E-01 
Q13443 Disintegrin and metalloproteinase domain-
containing protein 9 
ADAM9 5 594 670 710 791 760 662 1006 648 954 1.32 7.16E-01 
O00161 Synaptosomal-associated protein 23 SNAP23 2 92 102 107 123 137 127 131 111 155 1.32 7.18E-01 
Q8ND76 Cyclin-Y CCNY 2 72 87 81 94 113 131 97 106 112 1.31 7.34E-01 
P51811 Membrane transport protein XK XK 38 6724 7473 7533 9218 8101 8325 9530 8113 10695 1.30 7.39E-01 
Q92542 Nicastrin NCSTN 16 2643 2986 3368 3622 3536 3992 3852 3358 4501 1.30 7.42E-01 
Q9Y666 Solute carrier family 12 member 7 SLC12A7 33 5572 4922 6781 7408 10318 7599 6956 8022 7441 1.30 7.47E-01 
A2RU67 Uncharacterized protein KIAA1467 KIAA1467 2 231 260 275 325 189 250 485 296 210 1.29 7.55E-01 
Q8N370-3 Large neutral amino acids transporter small 
subunit 4 
SLC43A2 44 13969 8839 10092 13307 15015 13408 13226 20231 8611 1.28 7.73E-01 
P19256 Lymphocyte function-associated antigen 3 CD58 45 11514 9683 14983 20833 11869 11771 17879 13145 15077 1.27 7.79E-01 
O15498 Synaptobrevin homolog YKT6 YKT6 1 77 63 39 82 68 43 61 55 109 1.26 7.97E-01 
Q14254 Flotillin-2 FLOT2 8 2256 2263 1531 4789 1532 2097 2717 2894 1996 1.26 8.03E-01 
Q93070 Ecto-ADP-ribosyltransferase 4 ART4 26 8340 6735 5675 10540 8957 6267 9466 8423 8128 1.25 8.08E-01 
P78310 Coxsackievirus and adenovirus receptor CXADR 14 3167 2651 2800 2861 3033 3147 3160 4164 3460 1.25 8.12E-01 
P51790 H(+)/Cl(-) exchange transporter 3 CLCN3 14 2596 2727 2936 4867 2256 2623 4942 3341 2050 1.25 8.12E-01 
Q9UIW2 Plexin-A1 PLXNA1 40 5316 7287 6218 9013 9172 11923 6305 9095 7990 1.24 8.24E-01 
P08637 Low affinity immunoglobulin gamma Fc region 
receptor III-A 
FCGR3A 1 62 40 242 243 99 58 231 84 112 1.24 8.32E-01 
P28907 ADP-ribosyl cyclase 1 CD38 17 899 6389 8367 1925 4947 964 5446 6080 7831 1.24 8.33E-01 
P01112 GTPase HRas HRAS 2 656 517 462 696 659 679 637 765 594 1.22 8.55E-01 
Q6P1A2 Lysophospholipid acyltransferase 5 LPCAT3 1 67 66 60 89 70 55 82 80 72 1.21 8.66E-01 
Q9HCJ1 Progressive ankylosis protein homolog ANKH 3 472 364 445 534 408 299 677 397 481 1.21 8.67E-01 
Q9Y6M5 Zinc transporter 1 SLC30A1 49 11985 10554 13211 16054 17334 14415 11328 18387 13113 1.20 8.91E-01 
Q07065 Cytoskeleton-associated protein 4 CKAP4 7 1460 1427 252 232 388 229 1166 2029 563 1.20 8.92E-01 
P23284 Peptidyl-prolyl cis-trans isomerase B PPIB 1 109 71 7 22 14 5 56 154 12 1.19 8.98E-01 
P48067 Sodium- and chloride-dependent glycine 
transporter 1 
SLC6A9 2 254 268 253 224 264 448 287 283 353 1.19 9.03E-01 
P50416 Carnitine O-palmitoyltransferase 1, liver 
isoform 
CPT1A 2 264 308 301 337 297 328 468 295 276 1.19 9.04E-01 
Q9H3N1 Thioredoxin-related transmembrane protein 1 TMX1 1 47 51 45 46 51 51 54 68 46 1.18 9.14E-01 
Q02094 Ammonium transporter Rh type A RHAG 52 7462 7216 8759 8337 8531 9951 8189 10224 9255 1.18 9.18E-01 
Q9NP72-2 Ras-related protein Rab-18 RAB18 1 194 327 199 426 204 245 249 379 220 1.18 9.22E-01 
P98172 Ephrin-B1 EFNB1 18 3299 3407 4038 4919 3695 3650 4250 3792 4600 1.18 9.23E-01 
P04921 Glycophorin-C GYPC 206 33328 32546 28576 34062 29295 30269 37566 41837 31371 1.17 9.29E-01 
P00387-3 NADH-cytochrome b5 reductase 3 CYB5R3 3 148 130 77 97 75 71 147 175 94 1.17 9.30E-01 
Q92482 Aquaporin-3 AQP3 5 1214 1362 1252 1730 1247 1326 1220 1633 1635 1.17 9.30E-01 
P84085 ADP-ribosylation factor 5 ARF5 2 286 343 185 619 411 173 436 259 258 1.17 9.33E-01 
P98196 Probable phospholipid-transporting ATPase IH ATP11A 4 284 344 367 496 372 397 379 333 444 1.16 9.47E-01 
P09601 Heme oxygenase 1 HMOX1 1 79 99 58 43 91 56 72 115 87 1.16 9.47E-01 
Q9UMF0 Intercellular adhesion molecule 5 ICAM5 3 369 506 360 312 383 696 518 455 458 1.16 9.51E-01 
Q93050-3 V-type proton ATPase 116 kDa subunit a 
isoform 1 
ATP6V0A1 8 1228 1011 1314 1223 1204 1339 1259 1374 1483 1.16 9.52E-01 
Q13261 Interleukin-15 receptor subunit alpha IL15RA 8 1668 1747 1743 1796 2344 1052 3173 1445 1354 1.16 9.53E-01 
B2RUZ4 Small integral membrane protein 1 SMIM1 5 947 678 338 844 440 802 958 946 356 1.15 9.62E-01 
Q9Y5Z0 Beta-secretase 2 BACE2 5 328 1005 645 513 630 733 686 694 891 1.15 9.68E-01 
P33527 Multidrug resistance-associated protein 1 ABCC1 83 14571 14871 12565 13896 10360 19221 15126 18842 14216 1.15 9.70E-01 
P62191 26S protease regulatory subunit 4 PSMC1 7 1144 1645 1201 1965 1532 1405 1359 1295 1917 1.15 9.73E-01 
Q8IUW5 RELT-like protein 1 RELL1 12 1658 1400 1616 1756 1932 2024 1565 1922 1855 1.14 9.77E-01 
O75326 Semaphorin-7A SEMA7A 57 14034 8984 11617 16262 10123 11963 11424 15287 12712 1.14 9.85E-01 
Q10589 Bone marrow stromal antigen 2 BST2 11 1848 1414 2047 2804 2925 2196 1986 2236 1819 1.14 9.86E-01 
P49768 Presenilin-1 PSEN1 1 62 65 57 70 61 55 83 54 71 1.13 9.93E-01 
P35613 Basigin BSG 84 18356 21573 19196 21771 24115 25996 24897 22360 19720 1.13 9.93E-01 
Q9NV96 Cell cycle control protein 50A TMEM30A 20 4323 4077 4724 5205 5214 5620 4136 5382 5307 1.13 9.98E-01 
P13073 Cytochrome c oxidase subunit 4 isoform 1, 
mitochondrial 
COX4I1 2 588 516 97 89 102 77 495 751 110 1.13 1.00E+00 
Q8IZY2 ATP-binding cassette sub-family A member 7 ABCA7 42 9017 8325 7040 9440 7642 10578 5543 7783 14189 1.13 1.00E+00 
P35670 Copper-transporting ATPase 2 ATP7B 1 101 133 132 138 76 88 113 151 147 1.13 9.95E-01 
Q92859 Neogenin NEO1 2 40 65 70 67 58 75 72 62 63 1.12 9.92E-01 
P23276 Kell blood group glycoprotein KEL 132 22381 25093 26922 26374 22382 24615 29400 26065 27693 1.12 9.82E-01 
Q9NUQ9 Protein FAM49B FAM49B 1 49 48 30 49 46 52 63 37 41 1.11 9.65E-01 
Q9P035 Very-long-chain (3R)-3-hydroxyacyl-[acyl-
carrier protein] dehydratase 3 
PTPLAD1 1 46 42 26 38 28 31 51 48 25 1.10 9.49E-01 
Q9Y5S1 Transient receptor potential cation channel 
subfamily V member 2 
TRPV2 4 653 643 707 518 823 818 599 801 798 1.10 9.48E-01 
Q92485 Acid sphingomyelinase-like phosphodiesterase 
3b 
SMPDL3B 5 1131 760 1086 1018 1132 1143 1065 1172 1026 1.10 9.45E-01 
Q96BI3 Gamma-secretase subunit APH-1A APH1A 2 276 425 363 529 314 429 334 408 424 1.10 9.45E-01 
Q8WUD1 Ras-related protein Rab-2B RAB2B 1 101 150 146 122 150 103 103 101 230 1.09 9.42E-01 
O15439 Multidrug resistance-associated protein 4 ABCC4 161 35175 31325 38485 34277 36989 43698 40399 32901 40478 1.08 9.24E-01 
P62241 40S ribosomal protein S8 RPS8 1 196 241 45 97 56 19 154 282 84 1.08 9.10E-01 
P05186 Alkaline phosphatase, tissue-nonspecific 
isozyme 
ALPL 3 250 95 107 230 177 149 237 113 137 1.08 9.09E-01 
P61006 Ras-related protein Rab-8A RAB8A 5 3472 3476 2454 3098 2922 3276 3076 3650 3353 1.07 9.03E-01 
Q9UNQ0 ATP-binding cassette sub-family G member 2 ABCG2 22 5689 4886 6034 6057 6954 6041 5445 6920 5431 1.07 9.03E-01 
P23634-2 Plasma membrane calcium-transporting 
ATPase 4 
ATP2B4 1 122 167 100 159 149 165 99 169 145 1.06 8.88E-01 
Q5T3F8 Transmembrane protein 63B TMEM63B 20 4639 3342 4255 5712 2960 4425 6461 3266 3262 1.06 8.85E-01 
Q8NB49 Probable phospholipid-transporting ATPase IG ATP11C 8 1711 1981 2363 2333 2582 2504 1672 2000 2739 1.06 8.80E-01 
P61225 Ras-related protein Rap-2b RAP2B 9 1178 2028 2140 2299 1400 1921 1642 1690 2317 1.06 8.76E-01 
P49913 Cathelicidin antimicrobial peptide CAMP 4 173 312 1940 1826 714 387 99 223 2237 1.06 8.75E-01 
O75695 Protein XRP2 RP2 3 325 379 301 403 359 334 297 358 403 1.05 8.71E-01 
P20339 Ras-related protein Rab-5A RAB5A 4 205 231 218 293 273 201 179 226 283 1.05 8.71E-01 
P21439-2 Multidrug resistance protein 3 ABCB4 3 160 141 252 85 326 255 92 277 213 1.05 8.70E-01 
P08962 CD63 antigen CD63 1 10 21 54 81 25 26 6 9 73 1.05 8.62E-01 
P16150 Leukosialin SPN 1 48 54 68 31 55 137 47 50 81 1.05 8.60E-01 
Q9Y2G3 Probable phospholipid-transporting ATPase IF ATP11B 10 1300 1139 1367 1249 1888 1416 982 1352 1633 1.04 8.51E-01 
Q15836 Vesicle-associated membrane protein 3 VAMP3 3 306 217 202 213 195 324 297 266 189 1.04 8.43E-01 
Q9NTJ5 Phosphatidylinositide phosphatase SAC1 SACM1L 7 1092 1170 951 1318 879 828 1623 961 734 1.03 8.36E-01 
O60884 DnaJ homolog subfamily A member 2 DNAJA2 3 671 1028 684 1101 621 478 1207 540 701 1.03 8.25E-01 
P18085 ADP-ribosylation factor 4 ARF4 1 77 63 41 79 80 36 53 64 68 1.03 8.23E-01 
P08754 Guanine nucleotide-binding protein G(k) 
subunit alpha 
GNAI3 4 743 824 597 828 865 656 706 690 821 1.02 8.20E-01 
A1A5C7 Solute carrier family 22 member 23 SLC22A23 26 5784 7746 5948 8519 7355 9764 4631 7545 7757 1.02 8.18E-01 
Q8NHG7 Small VCP/p97-interacting protein SVIP 2 642 388 368 391 479 558 373 527 527 1.02 8.14E-01 
P51795-2 H(+)/Cl(-) exchange transporter 5 CLCN5 1 40 35 32 54 35 37 35 48 25 1.02 8.10E-01 
Q14773 Intercellular adhesion molecule 4 ICAM4 67 17849 13730 16311 12510 8205 15983 15383 19049 14028 1.01 7.97E-01 
Q92956 Tumor necrosis factor receptor superfamily 
member 14 
TNFRSF14 6 1327 1232 1072 1288 1315 1673 1161 1382 1095 1.00 7.79E-01 
Q15904 V-type proton ATPase subunit S1 ATP6AP1 5 561 353 454 383 427 437 385 587 395 1.00 7.75E-01 
O15431 High affinity copper uptake protein 1 SLC31A1 6 1665 2053 1422 2712 1610 2073 1529 1866 1733 1.00 7.72E-01 
P35813-3 Protein phosphatase 1A PPM1A 5 541 786 678 968 677 648 646 690 664 1.00 7.70E-01 
P22694-2 cAMP-dependent protein kinase catalytic 
subunit beta 
PRKACB 2 419 377 248 539 386 505 415 253 369 0.99 7.65E-01 
Q92508 Piezo-type mechanosensitive ion channel 
component 1 
PIEZO1 87 12035 13875 11568 12062 18105 16664 11527 13112 12565 0.99 7.62E-01 
P25686 DnaJ homolog subfamily B member 2 DNAJB2 10 2120 2470 1536 2470 1980 2546 2823 1584 1666 0.99 7.60E-01 
P51793 H(+)/Cl(-) exchange transporter 4 CLCN4 4 591 471 546 578 569 584 496 701 381 0.98 7.40E-01 
P23634 Plasma membrane calcium-transporting 
ATPase 4 
ATP2B4 37 6391 9256 6145 8346 8764 7445 6069 7395 7885 0.98 7.39E-01 
O15162 Phospholipid scramblase 1 PLSCR1 5 936 697 840 1095 1288 1095 582 1182 656 0.98 7.38E-01 
Q9NY35 Claudin domain-containing protein 1 CLDND1 2 188 253 343 290 283 380 187 268 310 0.98 7.31E-01 
Q08722 Leukocyte surface antigen CD47 CD47 71 18272 15457 15715 14511 15596 14353 14432 19632 14094 0.97 7.29E-01 
Q5VW32 BRO1 domain-containing protein BROX BROX 1 180 206 120 222 147 149 143 219 125 0.96 7.06E-01 
P04843 Dolichyl-diphosphooligosaccharide--protein 
glycosyltransferase subunit 1 
RPN1 2 1129 1001 470 282 354 361 772 1331 378 0.95 6.93E-01 
Q969E2 Secretory carrier-associated membrane protein 
4 
SCAMP4 1 67 62 53 60 70 53 64 63 47 0.95 6.84E-01 
P63218 Guanine nucleotide-binding protein 
G(I)/G(S)/G(O) subunit gamma-5 
GNG5 1 467 425 236 412 418 396 315 411 343 0.95 6.81E-01 
P13987 CD59 glycoprotein CD59 58 14079 11466 15241 13358 11255 13600 11836 16193 10621 0.95 6.81E-01 
P43007 Neutral amino acid transporter A SLC1A4 1 59 116 107 131 106 118 78 62 126 0.94 6.70E-01 
Q9NP58 ATP-binding cassette sub-family B member 6, 
mitochondrial 
ABCB6 79 12902 11947 8541 13107 14168 13236 11089 10845 9367 0.94 6.62E-01 
P17927 Complement receptor type 1 CR1 81 19506 14424 18073 11199 15036 13132 15517 13556 19447 0.93 6.54E-01 
Q13336-2 Urea transporter 1 SLC14A1 52 11856 10329 10650 12486 9340 14119 10712 9134 10625 0.93 6.45E-01 
O60488 Long-chain-fatty-acid--CoA ligase 4 ACSL4 2 184 239 197 216 202 201 188 220 166 0.93 6.42E-01 
P41440 Folate transporter 1 SLC19A1 6 913 852 1856 1257 1487 1219 1152 831 1371 0.93 6.42E-01 
Q15109-6 Advanced glycosylation end product-specific 
receptor 
AGER 3 135 359 260 308 218 245 244 204 244 0.92 6.27E-01 
Q8TDB8-5 Solute carrier family 2, facilitated glucose 
transporter member 14 
SLC2A14 30 5829 5935 6942 5179 5960 4798 5801 5024 6148 0.91 6.08E-01 
P60953 Cell division control protein 42 homolog CDC42 4 1121 1223 1385 1303 1145 1220 966 1137 1273 0.91 6.04E-01 
Q13308-6 Inactive tyrosine-protein kinase 7 PTK7 6 448 543 390 432 536 388 501 349 394 0.90 5.96E-01 
Q5VY43 Platelet endothelial aggregation receptor 1 PEAR1 13 1878 2510 1849 1216 2711 1738 2234 1551 1832 0.90 5.95E-01 
Q9Y624 Junctional adhesion molecule A F11R 44 11988 10403 11173 12369 8948 7262 8211 10390 11623 0.90 5.95E-01 
Q00013 55 kDa erythrocyte membrane protein MPP1 30 9565 9495 8490 10239 8962 9648 7632 8436 8706 0.90 5.93E-01 
P20020 Plasma membrane calcium-transporting 
ATPase 1 
ATP2B1 26 5408 7240 5906 5647 6779 7122 4242 6585 5757 0.89 5.83E-01 
Q7Z3C6 Autophagy-related protein 9A ATG9A 1 73 204 76 300 69 125 163 106 43 0.88 5.66E-01 
O95562 Vesicle transport protein SFT2B SFT2D2 2 301 344 283 225 267 283 328 251 238 0.88 5.60E-01 
P29972 Aquaporin-1 AQP1 19 3732 3350 3734 3236 4665 2848 2491 3847 3186 0.88 5.59E-01 
P11166 Solute carrier family 2, facilitated glucose 
transporter member 1 
SLC2A1 361 87788 99221 92544 100919 85546 89671 79632 84632 81305 0.88 5.55E-01 
P04899-4 Guanine nucleotide-binding protein G(i) 
subunit alpha-2 
GNAI2 2 107 103 100 109 115 117 61 94 115 0.87 5.47E-01 
Q86T03-2 Type 1 phosphatidylinositol 4,5-bisphosphate 
4-phosphatase 
TMEM55B 1 33 21 18 25 23 32 14 29 20 0.87 5.45E-01 
Q08357 Sodium-dependent phosphate transporter 2 SLC20A2 1 127 174 164 154 138 138 158 110 133 0.86 5.26E-01 
Q96D31 Calcium release-activated calcium channel 
protein 1 
ORAI1 4 1092 1253 652 1331 1072 1616 504 1060 1014 0.86 5.23E-01 
P14207 Folate receptor beta FOLR2 3 769 795 882 631 618 535 766 845 471 0.85 5.06E-01 
Q5FWE3 Proline-rich transmembrane protein 3 PRRT3 2 155 174 165 135 143 160 125 171 113 0.83 4.71E-01 
Q92581-2 Sodium/hydrogen exchanger 6 SLC9A6 7 1410 1355 1191 1354 1115 1432 1220 1151 902 0.83 4.65E-01 
Q99828-2 Calcium and integrin-binding protein 1 CIB1 2 188 101 150 143 145 149 110 113 140 0.83 4.61E-01 
Q9BX97 Plasmalemma vesicle-associated protein PLVAP 12 3754 1508 2719 2031 3921 5514 1895 1541 3120 0.82 4.54E-01 
O60931-2 Cystinosin CTNS 2 163 286 191 165 177 145 130 152 242 0.82 4.49E-01 
Q8IU68 Transmembrane channel-like protein 8 TMC8 8 3097 1189 2353 2027 1464 2425 1529 1673 2220 0.82 4.46E-01 
P16452-2 Erythrocyte membrane protein band 4.2 EPB42 76 13112 14488 19292 15130 16042 14301 10599 11054 16521 0.81 4.42E-01 
Q9H8H3 Methyltransferase-like protein 7A METTL7A 2 143 68 71 108 112 112 88 80 62 0.81 4.41E-01 
P32942 Intercellular adhesion molecule 3 ICAM3 13 3475 1237 1850 2058 2496 4787 1048 1774 2514 0.81 4.40E-01 
P29966 Myristoylated alanine-rich C-kinase substrate MARCKS 2 317 339 95 491 55 54 263 288 59 0.81 4.40E-01 
O15400 Syntaxin-7 STX7 1 507 501 489 559 358 408 364 545 305 0.81 4.35E-01 
P27105 Erythrocyte band 7 integral membrane protein STOM 62 13702 14169 9583 10880 7715 24912 5122 12432 12758 0.81 4.34E-01 
Q96DD7 Protein shisa-4 SHISA4 1 106 65 54 199 54 68 43 67 71 0.80 4.22E-01 
P30825 High affinity cationic amino acid transporter 1 SLC7A1 6 1036 1706 2707 1032 1435 1146 1854 711 1755 0.79 4.06E-01 
Q12907 Vesicular integral-membrane protein VIP36 LMAN2 6 975 1153 3269 907 1521 1392 1657 1499 1099 0.79 3.98E-01 
Q8WWI5 Choline transporter-like protein 1 SLC44A1 4 1228 1381 1245 784 1080 1312 794 1123 1110 0.79 3.94E-01 
O15554 Intermediate conductance calcium-activated 
potassium channel protein 4 
KCNN4 14 4476 4325 3807 3477 4454 3440 2693 3024 4118 0.78 3.85E-01 
O95297 Myelin protein zero-like protein 1 MPZL1 6 1850 1074 1977 1680 1412 1314 1112 1375 1274 0.77 3.64E-01 
P51148-2 Ras-related protein Rab-5C RAB5C 5 571 461 513 567 551 519 358 357 452 0.76 3.45E-01 
O14828 Secretory carrier-associated membrane protein 
3 
SCAMP3 2 433 344 306 410 324 451 231 295 288 0.75 3.38E-01 
P11169 Solute carrier family 2, facilitated glucose 
transporter member 3 
SLC2A3 7 561 1451 565 1641 599 648 656 668 592 0.74 3.26E-01 
Q7Z403 Transmembrane channel-like protein 6 TMC6 7 2021 610 1424 1114 880 1395 742 992 1277 0.74 3.25E-01 
P04156 Major prion protein PRNP 11 2225 2768 2187 2389 2274 3815 2380 1098 1854 0.74 3.25E-01 
Q12846 Syntaxin-4 STX4 1 116 128 106 84 80 79 101 93 66 0.74 3.23E-01 
A6NFX1 Major facilitator superfamily domain-
containing protein 2B 
MFSD2B 5 1614 1620 1202 1056 1330 1411 1051 1240 982 0.74 3.17E-01 
O00461 Golgi integral membrane protein 4 GOLIM4 2 800 286 318 173 91 150 321 486 228 0.74 3.15E-01 
Q6DD88 Atlastin-3 ATL3 1 535 290 27 65 32 249 253 357 18 0.74 3.15E-01 
Q8N4S9 MARVEL domain-containing protein 2 MARVELD2 3 296 317 263 262 281 311 142 207 293 0.73 3.07E-01 
Q68DH5 LMBR1 domain-containing protein 2 LMBRD2 1 395 356 455 287 254 305 319 354 201 0.72 2.96E-01 
O15455 Toll-like receptor 3 TLR3 1 178 176 108 180 118 271 104 90 140 0.72 2.95E-01 
Q53TN4 Cytochrome b reductase 1 CYBRD1 3 558 440 349 278 391 418 287 349 305 0.70 2.59E-01 
P28906 Hematopoietic progenitor cell antigen CD34 CD34 4 1275 561 511 647 1451 2121 343 676 599 0.69 2.45E-01 
P25942 Tumor necrosis factor receptor superfamily 
member 5 
CD40 1 162 169 157 98 177 252 50 168 117 0.69 2.41E-01 
Q9UL25 Ras-related protein Rab-21 RAB21 1 34 31 33 27 30 24 17 19 31 0.68 2.35E-01 
Q9NP59 Solute carrier family 40 member 1 SLC40A1 96 26172 30560 31029 13472 20240 23717 23691 18301 17590 0.68 2.32E-01 
P13598 Intercellular adhesion molecule 2 ICAM2 2 668 560 971 604 672 751 446 565 476 0.68 2.28E-01 
P43250-2 G protein-coupled receptor kinase 6 GRK6 2 102 120 83 105 116 99 79 56 70 0.67 2.23E-01 
P61020 Ras-related protein Rab-5B RAB5B 1 1194 808 766 1027 967 795 567 673 543 0.64 1.87E-01 
O95197 Reticulon-3 RTN3 1 184 205 191 110 91 83 106 181 85 0.64 1.82E-01 
Q9H4G4 Golgi-associated plant pathogenesis-related 
protein 1 
GLIPR2 4 715 750 495 552 455 467 448 317 482 0.64 1.77E-01 
O00421-2 C-C chemokine receptor-like 2 CCRL2 10 1772 1586 1422 615 1246 1455 981 1275 767 0.63 1.72E-01 
Q99808-2 Equilibrative nucleoside transporter 1 SLC29A1 69 16871 17545 18663 17824 15297 13370 11396 9321 12691 0.63 1.69E-01 
P47900 P2Y purinoceptor 1 P2RY1 5 295 569 461 398 384 302 330 269 231 0.63 1.66E-01 
Q9BTU6 Phosphatidylinositol 4-kinase type 2-alpha PI4K2A 4 528 292 299 429 321 394 223 234 233 0.62 1.55E-01 
Q6ZWT7 Lysophospholipid acyltransferase 2 MBOAT2 2 335 519 481 351 281 277 278 270 273 0.62 1.54E-01 
P25445 Tumor necrosis factor receptor superfamily 
member 6 
FAS 26 14653 8510 14592 6481 13991 10380 7894 8620 6577 0.61 1.49E-01 
P63000-2 Ras-related C3 botulinum toxin substrate 1 RAC1 19 5280 5084 5275 4550 3786 3970 2540 3297 3461 0.59 1.31E-01 
Q13530 Serine incorporator 3 SERINC3 13 2816 2498 2387 2842 1761 2328 2184 882 1408 0.58 1.18E-01 
P62834 Ras-related protein Rap-1A RAP1A 9 1852 1963 1881 1662 1815 1758 989 1189 974 0.55 9.35E-02 
Q15223 Poliovirus receptor-related protein 1 PVRL1 28 5288 6530 6731 5852 5162 3964 3395 2946 3882 0.55 9.16E-02 
Q8N9N7 Leucine-rich repeat-containing protein 57 LRRC57 10 2208 1574 1716 1297 2226 1793 706 788 1364 0.52 6.81E-02 
P02730 Band 3 anion transport protein SLC4A1 693 223434 192767 205221 137824 153679 134012 95150 100584 108756 0.49 4.96E-02 
O14523-2 C2 domain-containing protein 2-like C2CD2L 1 330 561 609 272 279 257 262 229 202 0.46 3.57E-02 
P09543 2',3'-cyclic-nucleotide 3'-phosphodiesterase CNP 15 2859 3125 3124 2506 3178 2482 1348 1030 1682 0.45 2.88E-02 
P27701 CD82 antigen CD82 10 1534 2505 2393 1412 936 1899 552 835 1465 0.44 2.79E-02 
Q8IWA5 Choline transporter-like protein 2 SLC44A2 19 3058 4574 4429 2080 2019 3525 1050 1865 2380 0.44 2.63E-02 
P32248 C-C chemokine receptor type 7 CCR7 3 1219 1715 767 349 785 551 621 479 506 0.43 2.45E-02 
P11049 Leukocyte antigen CD37 CD37 1 65 143 31 33 63 48 28 39 37 0.43 2.45E-02 
Q969X1 Protein lifeguard 3 TMBIM1 3 360 487 321 218 218 308 165 178 157 0.43 2.26E-02 
Q96HA4 Uncharacterized protein C1orf159 C1orf159 2 668 797 960 446 524 503 287 385 318 0.41 1.67E-02 
P53985 Monocarboxylate transporter 1 SLC16A1 5 318 581 478 253 201 407 198 121 212 0.39 1.14E-02 
P48509 CD151 antigen CD151 1 108 143 343 66 81 57 67 81 80 0.38 1.10E-02 
P49281-4 Natural resistance-associated macrophage 
protein 2 
SLC11A2 2 362 494 558 271 149 135 236 79 147 0.33 3.47E-03 
P04920 Anion exchange protein 2 SLC4A2 6 2459 2202 943 1538 469 933 674 575 526 0.32 2.78E-03 
Q13467 Frizzled-5 FZD5 2 101 213 300 22 33 181 27 49 85 0.26 6.08E-04 
Q96S97 Myeloid-associated differentiation marker MYADM 1 94 87 75 29 58 43 18 14 26 0.23 1.65E-04 
Q9H7M9 Platelet receptor Gi24 C10orf54 6 2365 2516 773 469 650 527 318 337 539 0.21 8.03E-05 
Q9UIJ5 Palmitoyltransferase ZDHHC2 ZDHHC2 1 429 473 574 184 114 287 107 97 108 0.21 7.86E-05 
P02724 Glycophorin-A (Unique) GYPA 
Unique 
128 64114 96792 86856 36597 35880 30445 19067 17062 11999 0.19 3.46E-05 
Q8NBI5-2 Solute carrier family 43 member 3 SLC43A3 18 7025 7781 7281 1325 1652 1471 1317 1110 1331 0.17 8.49E-06 
P14672 Solute carrier family 2, facilitated glucose 
transporter member 4 
SLC2A4 4 1763 1931 1340 745 376 446 319 231 222 0.15 2.65E-06 
O75387-2 Large neutral amino acids transporter small 
subunit 3 
SLC43A1 11 3163 5231 3606 307 394 943 244 379 635 0.10 2.24E-08 
 
List of all proteomic data from Figures 2b, 2c and Extended Data Figure 4. n=3 biologically independent samples per 
genotype group. All 295 proteins either anchored in the RBC membrane or having a transmembrane region. 
Signal:noise values were normalised as described in the Methods. The method of significance A was used to estimate 
the p-value that each protein ratio was significantly different to 1, with adjustment for multiple testing using 
Benjamini-Hochberg correction. Colour coding in the table is matched to the coloured protein dots in the scatter 
plot in Fig. 2b, indicating significance p-value thresholds of fold change differences in protein expression between 
Dantu homozygote and non-Dantu RBCs: red - p<0.0001; green - p<0.01; light blue - p<0.05; dark blue - p> 0.05 (i.e. 
non-significant). Proteins are ordered by magnitude of fold change expression differences between Dantu 
homozygotes and non-Dantu. Note that Glycophorin-A is split into peptides unique to Glycophorin-A and peptides 
shared with Dantu. 
 
Supplementary Table 5| Biomechanical properties of RBCs 
 
 Non-Dantu  
(Mean ± SD) 
Dantu heterozygote 
(Mean ± SD) 
Dantu homozygote 
(Mean ± SD) 
Number of samples 6 6 6 
Number of cells 249 252 247 
Bending modulus (10-20 J) 14.0 ± 1.5 14.0 ± 1.8 13.0 ± 2.7 
Tension (10-7 N/m) 6.0 ± 1.9 7.9 ± 2.8 8.8 ± 0.7 
Radius (µm) 4.2 ± 0.1 4.0 ± 0.1 3.9 ± 0.1 
Viscosity (10-3 Pa s) 20.5 ± 5.6 20.8 ± 5.3 23.5± 4.6 
 
The membrane mechanics of RBCs, measured with live video flickering spectrometry, were compared across Dantu 
genotypes. Six biological replicates were prepared for each genotype group. For each of these samples, the average 
RBC values for four mechanical parameters (bending modulus, tension, radius, and viscosity) were calculated from 
approximately 250 cells. The average values of the parameters from the six replicates were used to calculate the 




Supplementary Table 6 | Impact of RBC tension on membrane deformation and parasite invasion 
 
Invasion efficiency Genotype group Number of cells Tension (10-7 N/m) 
(Mean ± SD) 
Deformation score 
Successful  non-Dantu 44 1.7 ± 1.2 2/3 
 Dantu homozygotes 31 2.6 ± 2.2 2/3 
     
Failed  non-Dantu 40 8.8 ± 5.7 0/1 
 Dantu homozygotes 48 9.4 ± 4.9 0/1 
 
The impact of tension on membrane deformation induced by parasites during pre-invasion, and on subsequent 





































General term that describes the 
ability of a soft body to change its 
shape in response to an external 
force. 
 
Depending on the experimental 
protocol, it will correlate to a 
combination of RBC shape and 
size, cell viscosity, membrane 
bending and tension. 
 
Ektacytometry, 





Ligand binding to 











Osmotic stress Pa Pressure due to imbalance of 
solutes across a semipermeable 
membrane.  
 
A sudden change in the solute 
concentration around a cell will 
cause a rapid movement of water 
across its cell membrane through 
osmosis –  change in cell 




May correlate to a combination of 
RBC shape and size, cell viscosity, 

















Note that in principle 
each of μ, E, κ, has a 
dynamical dissipative 
counterpart, but they 





Pa s Resistance to deformation at a 
given rate. 
 
As probed by various techniques, 
Viscosity combines membrane + 
cytoplasm viscosities. 
 
May correlate to a combination of 
RBC shape and size, membrane 












reduced invasion  





N/m2 (or N/m 
for 2d) 
A material property that describes 
the ability of a soft body to change 
its shape in response to an 
external force. 
 
It is well defined for a 
homogeneous material (3d block 
or 2d sheet) but in the context of 
a red blood cell it will correlate to 
a combination of RBC shape and 














N/m2 (or N/m 
for 2d) 
Given by stress/strain in a specific 
deformation geometry- Measures 
the resistance of a material 
to elastic deformations. 
 
It is proportional to the material 
property μ, for a given geometry 





(or bending rigidity) 
J Energy required to bend a 
membrane, by changing its 
curvature. 
 
Depends on membrane 
asymmetry, thickness (including 
cytoskeleton and membrane 
proteins), lipid composition, lipid 








invasion efficiency  
[Koch 2017] 
 
Our work: Clearly 
decouples the 
effect of tension 






N/m Force needed to stretch the 
membrane. 
 
Different regimes depending on 
the `excess surface area’ of the 
cell membrane 
and on membrane-cytoskeleton 
adhesion. Once the membrane is 
















Summary of techniques used to measure the biophysical properties of red blood cells in some exemplified 
publications [Tomaiuolo 2014, Kim 2015]. Individual cell analyses: flickering spectroscopy [Evans 2008, Yoon 2009, 
Koch 2017], diffraction phase microscopy (DPM) [Park 2008], pipette aspiration [Evans 1984], atomic force 
microscopy (AFM) [Dulinska 2006, Sinha 2015], and optical tweezers [Dao 2003, Popescu 2006, Yoon 2008, Sinha 
2015].  
Bulk cell analyses: ektacytometry [Mohandas 1984, Schrier 1989], filtration [Reid 1976], electric field [Engelhardt 
1984], flow channels [Bow 2011]. 
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Parasite invasion preference for RBCs from donors across Dantu genotype groups (Dantu homozygous, Dantu 
heterozygous and non-Dantu) was measured using a flow cytometry-based preference invasion assay. RBCs from 
the three Dantu genotypes were differentially labelled with three concentrations of a fluorescent cytoplasmic dye, 
CellTrace Far Red (x-axis), distinguishing the three RBC populations, while parasite-infected RBCs were detected with 
a fluorescent DNA dye, SYBR Green I (y-axis). The dot plot represents preference invasion data from 3D7 laboratory 
parasite strain generated by flow cytometry, with the Dantu homozygous, heterozygous and non-Dantu RBCs 
labelled with 1uM, 4uM and 16uM CellTrace Far Red, respectively. The four distinguishable populations in the dot 
plot are: unlabeled, infected RBCs (upper left panel, “Q1”); labeled, infected RBCs (upper right panel, “Q2”); labeled, 
uninfected RBCs (lower right panel, “Q3”); and unlabeled, uninfected RBCs (lower left panel, “Q4”). Gates are drawn 
around the three clusters of labeled parasitised RBCs in Q2, with the percentage of parasitised RBCs in each cluster 
indicated. The flow-cytometry based preference invasion experiments were repeated three independent times with 
similar results. 
